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ABSTRACT
We developed a unique methodology to selectively irradiate the vascular
endothelium in vivo to better understand the role of vascular damage in causing
normal tissue radiation side-effects.The relationship between vascular
endothelial cell apoptosis and intestinal crypt stem cell death was evaluated
using uniform whole-body and selective vascular irradiation techniques. Mice
received whole-body epithermal neutron beam irradiation. Additional dose was
selectively targeted to endothelial cells from the short-ranged (5-9 pm) particles
released from neutron capture reactions in 10B confined to the blood by
incorporation into 70-90 nm-diameter liposomes. Mice also received uniform
photon doses above and below the threshold for death from the gastrointestinal
(GI) syndrome. When plotted versus neutron beam dose, the crypt microcolony
assay showed the same dose response for both the neutron beam-only and
neutron beam plus boronated liposome groups. The added dose selectively
delivered to the microvasculature did not cause any additional crypt loss. Jejunal
cross-sections were prepared 4 hrs after irradiation and stained with TUNEL to
observe and score apoptotic cells in the villus lamina propria. To uniquely identify
the type of cell undergoing apoptosis in the lamina propria, intestinal specimens
from various mice in the TUNEL studies were sectioned and stained with Meca-
32 to identify endothelial cells and caspase-3 to identify apoptotic cells and
visualized using dual-fluorescence microscopy. The TUNEL data showed a low
level (-2 apoptotic cells per villus) of apoptosis in the lamina propria for both the
uniform (photon or neutron) and selective vascular irradiation conditions that was
independent of the administered dose. The dual-fluorescence studies indicated
that most apoptotic bodies in the lamina propria were not endothelial cells but,
rather, apoptotic leukocytes. These data demonstrate that there is no causal
relationship between vascular endothelial cell apoptosis and crypt stem cell
death in the mouse small intestine.
Thesis Supervisor: Jeffrey A. Coderre, Ph.D., Associate Professor of Nuclear
Science and Engineering, Massachusetts Institute of Technology
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The role of vascular damage in normal tissue radiation side effects (both
acute and late) has been a matter of considerable debate for many years. The
debate is largely centered on the role of vascular damage (apoptosis) in acute
radiation effects, although there are some unanswered questions regarding the
role of vascular damage in the onset of late radiation effects as well. These
debates still exist largely due to the lack of experimental techniques to selectively
increase the radiation dose to one target cell population in vivo (e.g. the vascular
endothelium) while keeping all others relatively unscathed. Conventional
irradiation techniques only allow for uniform irradiation where all cells in the
tissue receive the same radiation dose.
Our goal in this project was to develop a methodology to selectively
irradiate the vascular endothelium in order to address and hopefully resolve
some of the unanswered questions and unresolved controversies that still exist in
the radiation biology community. A selective vascular irradiation methodology
exists in the central nervous system (CNS) where the blood-brain barrier can be
exploited to gain vascular specificity (these techniques will be described later).
However, we wanted to find a general technique that could be applied to any
tissue or tumor where it would be interesting to explore the effects of vascular
damage in that system. This thesis will describe a generalized methodology for
selective vascular irradiation and will present the proof-of-principle results that
were obtained in a very interesting tissue system: the mouse small intestine.
1.2 Background
1.2.1 Radiation damage in normal tissues (acute and late)
The critical events that lead to the ultimate depletion of tissue structure
and function are initiated at the time of irradiation. The eventual manifestation of
radiation effects critically depends on tissue type and cell turnover kinetics as
well as the magnitude of the radiation dose. Radiation damage in normal tissue is
traditionally separated into 'early' (acute) and 'late' effects, where, for late effects,
there may be a clinically 'silent' period before the damage manifests itself. Stem
cell based, rapidly-renewing tissues such as the small intestine, bone marrow
and oral mucosa are classic examples of acute responding tissues. It is generally
accepted that damage to the regenerative stem cell populations is the initiating
lesion leading to radiation effects in these tissues. Once the regenerative stem
cell populations die due to radiation exposure, the loss of tissue structure and
function is very quick to follow, usually within a few days or weeks after radiation
exposure [1]. There is, however, a hypothesis that exists in the radiation biology
community that claims that vascular damage, rather than direct stem cell damage,
is the cause of acute radiation effects.
Late radiation effects typically occur in slowly proliferating tissues such as
the lung, kidney, liver and CNS. Fibrosis, atrophy, vascular damage, neural
damage and negative growth effects are the typical radiation-induced late effects,
and they tend to develop months to years after radiation exposure [1].
Researchers now believe that vascular damage may be responsible for
promoting the conditions required for late effects, namely chronic inflammation
(more on this later).
1.2.2 The role of vascular damage in normal tissue toxicity (late effects)
1.2.2.1 Late radiation effects in the small intestine
Once surviving crypt stem cells have repopulated the intestinal epithelium
to fully regain optimal tissue function after radiation exposure, it would seem that
the tissue has thwarted severe and long-lasting effects. However, at sufficiently
high radiation doses (but still below those that would result in death from the
gastrointestinal (GI) syndrome) the small intestine is susceptible to late radiation-
induced fibrosis that occurs months to even years after exposure [2]. It has been
hypothesized that radiation damage to the vascular endothelium plays a critical
role in the onset of late tissue fibrosis [3], although the exact mechanism remains
unclear. Regardless, the onset of tissue fibrosis is the direct result of the complex
interplay between interconnected cell signaling networks [2, 4]. It has been
proposed that vascular damage is responsible for the onset of a chronic
inflammatory state, where inflammatory cytokine signaling persists beyond the
point of normal wound healing to ultimately result in tissue scarring, or fibrosis.
Up-regulation of various inflammatory cytokines, including transforming
growth factor-,8 (TGF-,8) [5], tumor necrosis factor-a (TNF-a) and interleukin-1 (IL-
1) has been reported in irradiated tissue [6]. Impairment of microvascular function
has been implicated in the late radiation response of the small intestine in reports
showing a dose-dependent decrease in microvascular thrombomodulin, which
results in elevated levels of thrombin. Elevated thrombin levels will then activate
the inflammation response, and the active feedback loop in TGF-8 and TNF-a
maintains the suppressed thrombomodulin levels, thus perpetuating inflammatory
signaling [4, 7]. Thus, there is strong, yet indirect, evidence showing that
microvascular radiation damage mediates the late radiation response in the small
intestine.
1.2.2.2 Late radiation effects in the CNS
Researchers have previously employed a selective vascular irradiation
methodology in the rat CNS where the blood-brain barrier was used to restrict the
widely used boron neutron capture therapy (BNCT) compound, sulfhydryl boron
hydride (Na2B12H 11SH, BSH), to the blood. Subsequent irradiation with thermal
neutrons selectively elevated the dose delivered to the CNS microvasculature
(more detail on this technique later). They were able to show that vascular
damage was responsible for the onset of late (7 months) necrosis in the rat
spinal cord [8-12]. In these studies, O-2A glial progenitor cells survived selective
vascular irradiation conditions, which indicated that vascular radiation damage
played a critical role in the onset of late radiation effects but had no effect on the
early radiation response in that system. Similar studies were carried out in the rat
brain where the loss of neural precursor cells was correlated with stem cell dose
and not the added dose selectively delivered to the vasculature [13].
There is clear evidence from the studies outlined above that vascular
damage plays a role in the onset of late radiation effects in normal tissue (the
exact damage mechanisms are still unknown). However, the primary controversy
surrounding the role of vascular damage in normal tissue radiation toxicity is
centered on acute radiation effects.
1.2.3 Controversies surrounding the proposed role of vascular damage in
acute radiation effects
1.2.3.1 Controversy surrounding the proposed role of vascular damage in the
acute lung radiation toxicity (radiation pneumonitis)
A rather old controversy exists in the lung, where it has been reported by
Fuks et al. that radiation-induced endothelial apoptosis is responsible for the
subsequent onset of radiation-induced pneumonitis in the lung [14]. There they
showed that vascular endothelial cells in the lung underwent apoptosis ~ 6-8 hrs
after clinically relevant radiation doses, and that administration of basic fibroblast
growth factor (bFGF) inhibited apoptotic death in endothelial cells. Administration
of bFGF immediately before and after radiation exposure inhibited vascular
endothelial apoptosis in mouse lung and subsequently protected the animals
from the development of lethal radiation pneumonitis [14]. However, a conflicting
report was published shortly thereafter, in direct response to the Fuks et al.
report, that demonstrated the failure of bFGF to protect the lung from radiation-
induced pneumonitis via the vascular endothelial apoptosis pathway [15].
Nothing more has been presented on this topic since then.
1.2.3.2 Controversy surrounding the proposed role of vascular damage in tumor
cell death
Another recent debate has centered on the role of vascular endothelial
apoptosis in the response of tumors to radiation therapy. It was reported that
vascular endothelial apoptosis mediates tumor radio-sensitivity [16]. Briefly, it
was shown that tumors implanted in mice deficient in acid sphingomyelinase or
Bax (two pro-apoptotic genes purported to mediate vascular endothelial
apoptosis) showed significant radio-resistance compared to their wild-type
counterparts. It was therefore concluded that endothelial apoptosis regulates the
tumor response to radiotherapy [16]. Again, this hypothesis was met with
considerable controversy and discussion [17-20], and a conflicting report was
subsequently published showing that the intrinsic tumor cell radio-sensitivity is
the major determinant of the tumor response to radiation [21], not the intrinsic
radio-sensitivity of the tumor vasculature. Gerweck et al. altered the radio-
sensitivity of repair-deficient tumor cells with the double-strand break repair gene,
DNA-PKcs, which decreased the cell radio-sensitivity by a factor of -1.5. If
vascular damage was the determinant of tumor cell sensitivity, one would expect
tumors with and without DNA-PKcs transfection to show a similar radiation
response. They, however, did not. The ratio (± DNA-PKcs transfection) of growth
delay was -1.5 for all irradiation conditions [21].
1.2.3.3 Controversy surrounding the proposed role of vascular damage in the
acute small intestine radiation toxicity (stem cell death and the gastrointestinal
(GI) syndrome)
It has traditionally been assumed that the GI syndrome results from direct
damage to stem cells leading to a depletion of differentiated epithelial cells and a
complete loss of tissue structure and function at high doses. However, the GI
syndrome has recently been suggested to be a direct consequence of an early (4
hrs) wave of apoptosis in the intestinal vascular endothelial cells [22]. These
authors irradiated mice with single whole-body photon doses of 8-15 Gy, some of
which were sufficient to cause death from the GI syndrome, and demonstrated
that it was possible to change the mode of death from the GI syndrome to the
bone marrow syndrome (in effect, producing about 3 Gy of radioprotection) when
endothelial cell apoptosis was suppressed genetically by deletion of the gene for
acid sphingomyelinase (a proapoptotic gene purported to mediate vascular
endothelial apoptosis), which controls endothelial cell apoptosis through a
ceramide pathway [23-28], or pharmacologically by administration of basic
fibroblast growth factor (bFGF). Immunohistochemistry showed that bFGF
localizes to the lamina propria and not the epithelial cells, including the stem cells
in the crypts [22]. Endothelial apoptosis was shown to be p53 independent. p53
(also known as 'tumor protein 53') is a transcription factor known to regulate the
cell cycle. It has a role as a tumor suppressor and has many anti-cancer
functions such as activating DNA repair proteins, initiating cell-cycle arrest during
DNA repair and initiating apoptosis [29]. Endothelial apoptosis has, however,
been shown to be acid sphingomyelinase dependent, where radiation activates
acid sphinomyelinase in the plasma membrane, which generates ceramide by
enzymatic hydrolysis of sphingomyelin. Ceramide then activates the apoptotic
response through the mitochondrial system [25-28]. The precise mechanism of
this proposed linkage between intestinal endothelial cell apoptosis and crypt
stem cell depletion leading to the GI syndrome remains unproven [28, 30, 31],
and it has been met with considerable controversy in the literature [32, 33].
Critics of this theory have countered using the argument that if
microvascular apoptosis (and subsequent microvascular dysfunction) initiates
intestinal crypt stem cell death, the mechanism would be hypoxic or ischemic
death. The resulting intestinal crypt survival curves would initially be steep for
well oxygenated cells after a single radiation dose, and then tend to be shallower
for subsequent, fractionated doses from the resultant tissue hypoxia due to
microvascular dysfunction. However, the published survival data that exist do not
show any effect due to tissue hypoxia [33-36]. Also, the rapid tissue repopulation
due to surviving crypt stem cells following radiation exposure would be
impossible with a disrupted capillary network [33]. Critics have also noted that
bFGF (or other growth factors) has been reported to confer radioprotection [37-
42] to the apoptosis-susceptible crypt epithelium [39, 43] through cell cycle delay
in G1 [44] or stimulating epithelial proliferation [45]. Finally, Potten [46] has
recently reported that although high levels of crypt epithelial apoptosis were
observed at 4 and 10 hrs post-irradiation, little or no endothelial apoptosis was
evident after using the same radiation doses and staining techniques reported by
Paris et al. [22, 46]. Clearly, there is a need for novel irradiation techniques that
will allow the direct testing of most, if not all, of these controversial hypotheses.
Time of death, or more specifically, mode of death following whole-body
radiation exposure is not an adequate endpoint for radiation biology studies. We
know from classical radiation biology experiments that the time of death due to
the GI syndrome can be affected by the intrinsic radio-sensitivity of the
hematopoietic bone marrow cells [47]. Mason et al. showed that intestinal stem
cell survival was the same in mice that received either whole-body irradiation or
just abdominal irradiation (shielded bone marrow). However, the LD50so (lethal
dose in 50% of the population) shifted from -20 Gy to -16 Gy when the
irradiation conditions were changed from total abdominal to whole-body
irradiation conditions. Thus, the LDso was shifted by ~ 4 Gy, which can be
attributed to the influence of bone marrow sensitivity on time of death. Therefore,
animal survival after large radiation doses (in the case of Paris et al., ~15 Gy) is
not solely related to intestinal stem cell survival but, rather, depends on the
combined influence of both intestinal and hematopoietic stem cell sensitivities
[47]. Ambiguities are thus incorporated into the Paris et al. conclusions, because
we know from the work of Mason et al. that time (and mode) of death can be
influenced by multiple factors.
1.2.3.4 The need for a selective vascular irradiation technique as a tool for direct
mechanistic studies into normal tissue radiation effects
Selective vascular irradiation techniques have been used by researchers
to explore the role of vascular damage in CNS radiation toxicities. Specifically
they were able to show that vascular damage was responsible for the onset of
late necrosis in the rat spinal cord, whereas glial progenitor cell survival was
unaffected by selective vascular irradiation [12, 13]. They exploited the blood-
brain barrier to restrict a 10B enriched compound (BSH) to the blood. Subsequent
irradiation with thermal neutrons resulted in an elevated dose to the vascular
endothelium (from the short range (5-9 pm) reaction products (a and 7 Li ions)
released from the boron neutron capture reaction) relative to the simultaneous
neutron beam dose delivered uniformly to the vessels and surrounding tissue.
This technique will not work outside of the CNS, because BSH will diffuse from
the blood stream into the surrounding tissues resulting in a uniform 10B dose to
both the vascular endothelium and surround tissues.
There is clearly a need for a generalized methodology for selective
vascular irradiation to address the multiple controversies that exist for vascular
damage in acute radiation effects as well as the unanswered questions regarding
the role of radiation damage in the onset of late radiation effects. The specific
methodology we employed for a generalized scheme to selectively irradiate the
vascular endothelium is, in principle, similar to the CNS studies, but will be
outlined at the end of this introduction and will be explained in detail in
subsequent chapters.
1.2.4 The mouse small intestine: an ideal system for selective vascular
irradiation studies
The mouse small intestine is an ideal system for selective vascular
irradiation studies, because it exhibits both acute and late effects and has clinical
relevance in that gastrointestinal tract sensitivity limits the amount of radiation
that can be delivered to the abdominal region during cancer therapy. The stem
cells that regenerate the epithelial lining of the small intestine are highly sensitive
to radiation exposure [46, 48], and the dose response for stem cell death in the
small intestine has been studied in great detail [34-36, 46, 48-51]. It is widely
accepted that radiation targets the intestinal stem cells, but some researchers
now think that vascular damage is the primary lesion leading to stem cell death.
The small intestine has also been shown to have a late effect (fibrosis) [2, 3], and
vascular damage may be involved with this process. The role of vascular
damage in the small intestine radiation toxicity is either highly controversial or
unanswered.
1.2.4.1 Anatomy of the small intestine
The small intestine is a classic example of a stem cell-based, rapidly-
renewing tissue. The small intestine is a tubular organ comprised of a monolayer
of columnar epithelial cells, which surround a complex connective tissue and
vascular network to form the familiar finger-like projections called "villi". Epithelial
cells originate from within the crypts of LieberkOhn that reside at the base of villi
(Figure 1-1). Epithelial cells differentiate as they migrate up the villus in a vertical
fashion [46, 52, 53], where they ultimately perform their prescribed functions
(secretion, absorption and protection against the gut microflora), die and slough
off at the villus tip; the total transit time taking ~ 3-4 days. This continuous cell
loss is perfectly balanced by cell regeneration from within the crypts. It has been
estimated that some 250 cells reside in a crypt, and among those approximately
150 exhibit cell cycle times that are as rapid as any mammalian cell system (-12
hrs) [46]. Approximately 6-9 crypts service a single villus. This indicates that each
villus loses between 1000 and 1400 cells per day. It is also known that each
epithelial cell is continuously moving with a velocity of approximately one cell
diameter per hour [46, 54].
Experiments have shown that vertical epithelial movement is restricted to
a columnar structure with little or no horizontal movement or mixing between
neighboring columns [46, 52, 53, 55]. This implies that there is a strong cell-
lineage organization to the epithelial structure, where cells of equal age move
together as they differentiate and progress through their life cycles. Using tritiated
thymidine to label cells in S-phase, experiments have defined and verified the
epithelial cell migration velocity, and have identified the position from within the
crypt where all cells in the columnar structure originate. This defines the position
of "lineage ancestor stem cells" [46, 54, 56]. Tritiated thymidine studies have also
been used to show the existence of a "proliferative zone", (where cells divide and
mature as they migrate) beyond which cell division ceases, to ultimately yield a
population of mature epithelial cells [46, 48, 57, 58].
These studies have thus shown that crypts contain a well defined set of
cell lineages, which are supported by a subpopulation of immortal stem cells that
exist in steady state at positions 4-5 (see Figure 1-1 for a description of crypt cell
position numbering) within the crypt. Stem cells live above a population of
protective Paneth cells that occupy positions 1-4 [46]. Each time a stem cell
divides, one daughter cell remains as the "immortal" stem cell, while the other
daughter moves to the next position within the crypt cell hierarchy. This daughter
then begins the differentiation process to become either a Paneth cell or a
functional epithelial cell. Early cell divisions take place within the "proliferative
zone" as some cells begin to move laterally to maintain the 3-dimensional crypt
structure and enter a cell lineage that may contain upwards of 6 defined
generations (Figure 1-1). Each generation corresponds to the cells' physical
location with the crypt structure, i.e. cells closer to the stem cells are 'younger'
than the cells above them. The functionality and architecture of this stem cell
system was inferred from the radio-labeling of migrating epithelial cells.
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Figure 1-1. Schematic of small intestine architecture and stem cell dynamics. The
delineation between 'actual and potential stem cells' and the dividing transit cells within
the proliferative zone is thought to occur at or around positions X, Y and Z [46]. This figure
was taken directly from reference 46 with permission from the publisher.
Specific stem cell markers do not currently exist. However, there has been much
effort put towards the development of such markers to ultimately verify the





1.2.4.2 Acute radiation pathology of the small intestine
The small intestine is one of the most radiation sensitive tissues in the
body, second only to the bone marrow, and exhibits a well defined set of acute
effects. Despite being slightly less radio-sensitive than the bone marrow,
radiation damage in the small intestine will manifest itself first because of the
rapid functional cell migration and stem cell turnover time (total transit time from
crypt to villus tip takes ~3-4 days). The radiation sensitivity of the small intestine
is the dose limiting factor in the treatment of abdominal tumors with radiation
therapy. In the mouse small intestine, a wave of apoptosis is observed in what
are thought to be crypt stem cells [60] as early as 3-6 hrs after irradiation with
doses as low as 0.01 Gy [46]. This effect saturates at ~ 1 Gy [61]. By 24 hrs post-
irradiation, crypt epithelial apoptosis levels fall to control levels. The wave of
radiation-induced apoptosis in crypts occurs almost primarily at crypt positions 4-
5 and not in the rapidly proliferating cells in the higher positions [46], although
apoptosis in higher positions may occur at later times [31]. There is no
dependence on LET (liner energy transfer) or dose rate for crypt epithelial
apoptosis, which implies that these cells do not undergo DNA repair processes
[46]. This early wave of crypt epithelial apoptosis is known to be p53 dependent
from experiments that have shown that p53 knockout mice (p53 -/-) exhibit
suppressed epithelial apoptosis 4 hrs after irradiation [22, 46, 62]. Despite the
apoptotic response of crypt stem cells after irradiation, there were no differences
in the dose response of crypt regeneration between wild-type and p53 knockout
mice [62].
Higher radiation doses are postulated to deplete the first few generations
of differentiated transit cells that still retain the ability to revert to fully-functional
stem cells [46]. Individual crypts are not sterilized until all of the actual and
potential stem cells are inactivated, which occurs at doses of about 8 Gy or
higher. The survival of one or more clonogenic cells per crypt allows its
regeneration. Doses above approximately 15 Gy sterilize virtually all of the crypt
stem cells, resulting in complete loss of the intestinal villi and death from the
gastrointestinal (GI) syndrome in about 4-5 days. When all of the crypt stem cells
are killed due to radiation exposure, the delicate system of continuous loss and
renewal is disrupted. Cells continue to be sloughed off from the tips of villi but are
no longer being replaced. As a result, the villi become denuded, shorten and
shrink. The gastrointestinal syndrome is characterized by the complete loss of
tissue structure and function resulting in loss of appetite, diarrhea, bleeding and
eventual bacterial infection from invading resident gut microflora [46, 63].
A quantitative measure of crypt stem cell survival has been developed and
is known as the 'crypt microcolony assay' or 'crypt regeneration assay' [35, 51].
The technique has endured many developmental iterations to finally converge on
a microscopic assay, where stem cell survival is quantitated 3-4 days after
radiation exposure. Surviving stem cells will repopulate the functional epithelial
cells by forming enlarged crypt-like foci that will eventually reconstruct the inner
structure of the small intestine. The crypt regeneration assay involves exposing
mice to various radiation doses, sacrificing the animals, harvesting the small
intestine at 3.5 days when the surviving stem cells have begun to regenerate the
crypts, preparing intestinal cross-sections (fixation in 10% formalin, embedding in
paraffin, cutting and staining with hematoxylin and eosin (H&E)) and scoring the
number of regenerating crypt-like foci per intestinal circumference [51]. The
number of regenerating crypts can then be plotted as a function of dose to
generate survival curves (Figure 1-2), which typically display a broad shoulder
and exponential decrease at high doses [46]. Various technical considerations
must be made while scoring regenerating crypts to account for oblique tissue
cuts and variations in crypt size relative to control crypts [64]. Criteria must also
be established to define a healthy regenerating crypt, which include the presence
of viable Paneth cells and contiguous crypt epithelial cells feeding a villus [64].
Given that the anatomy and radiation pathology of the small intestine is
known in great detail and that a quantitative assay exists to measure the extent
of radiation damage, this system is perfectly suited to explore the role of vascular
radiation damage in radiation toxicities. This system is also particularly
interesting because of the recent controversy that has developed regarding the
role of vascular damage in the onset of acute radiation effects. Therefore, the
small intestine was chosen for the proof-of-principle studies of the generalized
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Figure 1-2. Intestinal crypt regeneration assay. Intestinal cross-sections are prepared to
reveal individual cryptivillus units after H&E staining. Control sections display abundant
(-80-100 crypts per circumference depending on mouse strain) crypt numbers, whereas
crypt numbers begin to decrease as a function of dose (left). At right, plotting crypt
surviving fraction (normalized to controls) as a function of dose will generate survival
curves [46]. This figure was taken directly from reference 46 with permission from the
publisher.
1.3 Project objectives
This project contributes to the greater understanding of the role of
vascular damage in the onset of normal tissue radiation effects in general and in
the small intestine in particular. A unique methodology for the selective irradiation
of the vascular endothelium was developed in mice to explore the role of
vascular radiation damage in the normal tissue radiation response. This allowed,
for the first time, a direct measure of the role of microvascular damage in the
normal tissue radiation response without the need for complicating factors such
as growth factors or genetic manipulations (knockout mice). The intestinal crypt
regeneration assay was used to measure the effect of selective vascular
irradiation on intestinal crypt stem cell survival. Animal survival was used as an
endpoint to ascertain the role of selective vascular irradiation in the onset of
various early (acute) radiation syndromes. Vascular endothelial apoptosis was
measured in the mouse small intestine after selective vascular irradiation or
uniform external beam irradiation. This provided a resolution to the ongoing
debate regarding the role of vascular radiation damage (specifically apoptosis) in
the early radiation response in the mouse small intestine. Measurements were
made on early inflammatory cytokine levels in the brain and small intestine after
selective vascular irradiation or uniform external beam irradiation. This allowed,
for the first time, a method to parse out the role of vascular radiation damage in
the initiation of inflammatory signaling cascades, which may ultimately lead to the
onset of late radiation effects (specifically, radiation-induced fibrosis in the small
intestine). All of the methodologies described in this thesis can be abstracted
and/or modified for use in other normal tissues or in tumors.
1.4 Study design
Part 1: A unique methodology for the selective irradiation of the vascular
endothelium outside of the central nervous system (CNS) was developed. This
technique utilized the short range (5-9 pm) a and 7Li particles released from
boron-neutron capture reactions restricted to the blood stream of live mice. Novel
10B-containing compounds (boronated Dextran-77 and boronated liposomes)
were developed or modified for use in this methodology. Vascular dosimetry (as
well as whole-body neutron dosimetry) was carefully considered. Monte-Carlo
simulations were performed to determine the rate of dose drop-off as a function
distance from the vessel lumen. Mouse biodistribution studies were performed for
each compound to determine the 10B concentrations in blood and normal tissue
as a function of time post-injection. Preliminary mouse irradiation studies were
conducted using the intestinal crypt regeneration assay and mouse survival as
endpoints to measure the biological response after selective vascular and
uniform irradiation conditions. The optimal compound (boronated liposomes) was
chosen from these studies and was subsequently used for the rest of the project.
Part 2: Boronated liposomes were used in a study of the acute response in the
mouse small intestine, which culminated in a publication in the Proceedings of
the National Academy of Sciences [63]. Rigorous dosimetry considerations are
presented as well as full intestinal crypt survival curves and mouse survival data
for neutron beam-only and selective vascular irradiation conditions. The main
conclusions from this study are: 1. The extra dose delivered by the 10B-containing
compound during neutron irradiation was fully restricted to the vascular
endothelium. 2. The compound itself does not leak from the vasculature. 3. The
added dose selectively delivered to the vascular endothelium does not cause
enhanced crypt death beyond that produced by the neutron beam alone.
Therefore, vascular damage (extra dose) does not contribute to the overall
radiosesitivity of intestinal crypt stem cells. 4. Conclusion 3 was extended and
verified using an animal survival (mode of death) endpoint. The added radiation
dose selectively delivered to the vascular endothelium did not cause a transition
in the mode of death from the bone marrow syndrome to the GI syndrome when
the neutron beam dose was brought just below the threshold for death from the
GI syndrome. Thus, the uniform neutron beam dose to the crypts was solely
responsible for this transition. The manuscript itself will serve as the main body of
text for this part.
Part 3: The selective vascular irradiation methodology developed and tested in
parts 1 and 2 was used in this part of the project to directly address the
controversy regarding the role vascular endothelial apoptosis in the radiation-
induced GI syndrome. The debate still exists largely due to the lack of
experimental techniques to selectively irradiate one target cell population in order
to directly test these hypotheses. Instead, researchers indirectly inferred a
vascular cause by administering various compounds (in this case growth factors)
and using genetically modified animals (knockout mice). These conventional
techniques may introduce unpredictable complications and influence the
interpretation of the data. Thus, our technique provides a way to directly test the
role of vascular endothelial apoptosis in the radiation-induced GI syndrome by
allowing us to selectively elevate the dose to one target cell population, namely
the vascular endothelium, while keeping all others relatively unharmed.
Vascular endothelial apoptosis was measured in irradiated mouse small
intestine using uniform photon irradiation (x-rays and gamma rays), uniform
neutron irradiation and the selective vascular irradiation methodology introduced
earlier. Various tissue stains for apoptosis are presented as well as dose
response data that show the incidence of apoptosis in the villus lamina propria as
a function of vascular dose for 4 different irradiation modalities. These studies
ultimately culminated in a publication in the International Journal of Radiation
Oncology Biology and Physics [65]. The main conclusions from this study are: 1.
Vascular endothelial apoptosis did not occur at the level originally reported by
Paris et al. [22] as the radiation dose crossed the threshold for death from the GI
syndrome using x-rays, gamma rays, neutrons-only and selective vascular
irradiation. Most significantly, the data Paris et al. presented using whole-body
gamma irradiation could not be reproduced. 2. Dual-fluorescence staining for
apoptosis and tissue-resident leukocytes (white blood cells) identified the
majority of the apoptotic bodies in these studies as apoptotic leukocytes. Thus,
vascular endothelial apoptosis is not causative in the radiation-induced GI
syndrome, which is a conclusion that largely refutes the claim that radiation-
induced endothelial apoptosis is the initiating lesion leading to stem cell death in
the small intestine [14, 22, 30, 31, 66]. The manuscript itself will serve as the
main body of text for this part.
Part 4: The selective vascular irradiation methodology was used to examine the
early expression of inflammatory cytokines, which may lead to the onset of late
radiation effects in the mouse small intestine. Tumor necrosis factor-a (TNF-a),
intercellular adhesion molecule-1 (ICAM-1), interleukin-1 (IL-1), interleukin-6 (IL-
6) and transforming growth factor-/t (TGF-f) levels were measured in tissue
following selective vascular irradiation and uniform whole-body irradiation using
real-time polymerase chain reaction (real-time PCR) and DNA microarray
analysis. Preliminary results indicate that ICAM-1 and TNF-a are upregulated
early on in response to radiation exposure in both the uniform and selective
vascular irradiation groups. The results show that there are differences between
the neutrons-only and selective vascular irradiation groups. These results will
serve as the foundation for future studies that will examine the role of vascular
radiation damage in the onset of late radiation effects, namely fibrosis in the
small intestine. This technique can also be applied to other late responding
tissues such as the brain and even the lung.
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Chapter 2: Selective Irradiation of the Vascular
Endothelium: Development of the 10B Carrier.
2.1 Introduction
The tissue response to radiation exposure is a complicated sequence of
events that involves many different cell types, i.e. vascular endothelium,
epithelium, nerve cells, etc. It is desirable to analyze the response of each
individual cell population to radiation exposure in order to elucidate the dynamic
cell signaling processes that occur between the different cell types within the
tissue architecture and then define the mechanism of radiation damage in the
tissue of interest. Which cell types are involved? What is the initiating lesion? In
what cell type does the lesion occur? These are the critical questions a radiation
biologist hopes to answer, and, theoretically, the most direct way to answer these
questions would be to selectively irradiate each cell type individually in vivo and
then examine the tissue response to this selective cell damage. Conventional
irradiation techniques do not allow for the selective irradiation of specific target
cell populations within a complex organism, and thus it is difficult to reveal
radiation damage mechanisms in various tissues.
Radiation damage in normal tissue is traditionally separated into 'early'
(acute) and 'late' effects, where, for late effects, there may be a clinically 'silent'
period before the damage manifests itself. Stem cell based, rapidly-renewing
tissues such as the small intestine, bone marrow and oral mucosa are classic
examples of acutely responding tissues. It is generally accepted that damage to
the regenerative stem cell populations is the initiating lesion leading to radiation
effects in these tissues. Once the regenerative stem cell populations die due to
radiation exposure, the loss of tissue structure and function is very quick to follow,
usually within a few days or weeks after radiation exposure [1]. There is, however,
a hypothesis that exists in the radiation biology community that claims that
vascular damage, rather than direct stem cell damage, is the cause of acute
radiation effects.
Late radiation effects typically occur in slowly proliferating tissues such as
the lung, kidney, liver and CNS. Fibrosis, atrophy, vascular damage, neural
damage and negative growth effects are the typical radiation-induced late effects,
and they tend to develop months to years after radiation exposure [1].
Researchers now believe that vascular damage may be responsible for
promoting the conditions required for late effects, namely chronic inflammation.
One of the more controversial topics in radiation biology today revolves
around the mechanism of crypt stem cell death in the mouse small intestine. A
recent report has suggested that apoptosis in the vascular endothelium is the
initiating lesion in the eventual onset of the radiation-induced gastrointestinal (GI)
syndrome [2]. The authors attempted to manipulate the microvasculature by
creating a mouse lacking acid sphingomyelinase (asmase -/-), which is the
enzyme responsible for initiating endothelial apoptosis through a ceramide
pathway [3-8], and by administration of basic fibroblast growth factor (bFGF),
which was purported to selectively protect the vascular endothelium from
radiation damage. They claimed that bFGF localizes to the lamina propria and
not the epithelial cells, including the stem cells in the crypts [2]. However, it has
already been shown that growth factors, including bFGF, are active outside of the
vasculature and confer some radioprotective effect on the intestinal epithelium,
either by stimulating stem cell proliferation, inhibiting cell-cycle progression or
preventing radiation induced apoptosis [9-13]. Clearly, there is a need for
improved irradiation modalities that will allow the selective irradiation of the
vascular endothelium, which will ultimately allow a more direct and less
complicated methodology to explore the role of vascular damage in the radiation-
induced GI syndrome.
Figure 2-1. Schematic of the boron neutron capture reaction. 10B will capture a thermal
neutron and split into two densely ionizing a and 7Li particles with energies of 0.84 and
1.47 MeV, respectively.
The boron-neutron capture (BNC) reaction (Figure 2-1) provides a unique
tool for probing the mechanisms of radiation damage in both normal tissues and
tumors. The stable minor isotope of boron, 10B, exhibits a large thermal neutron
capture cross section (3837 barns, 1 barn = 10-24 cm2) and will readily capture
thermal neutrons to form a metastable 11B nucleus, which will rapidly split into
two densely ionizing particles, a and 7Li, with ranges in soft tissue of
approximately 5 and 9 pm, respectively. If 10B can be confined to the blood
stream and coupled to external irradiation with thermal neutrons, the resultant
BNC reactions will selectively elevate the dose to the vascular endothelium, as
the ranges of the BNC reaction products are roughly equivalent to the inner
diameter of the smallest capillaries [14] (Figure 2-2). It would be impractical (and
dangerous) to attempt this technique with a soluble radioisotope to achieve
equivalent dose rates to what are attainable with the described BNC technique
(more on this later in the chapter).
cells
Figure 2-2. Schematic behind the selective vascular irradiation methodology. 10B is
confined to the blood stream (pink). The confined 10B will capture the thermal neutrons
delivered externally. The resultant BNC reactions will selectively elevate the dose to the
vascular endothelium (red circle) while simultaneously keeping the surrounding functional
cells (blue) at a lower dose.
The technique of selective vascular irradiation has been used in the
central nervous system (CNS) using a 10B containing compound, sulfhydryl boron
hydride (Na2B12H1 iSH, BSH), which does not cross the blood brain barrier. Thus,
the problem of confining 10B to the blood stream was solved without needing to
engineer a new 10B compound. The technique was used to test the hypothesis
that radiation damage to the CNS vascular network initiates the late development
of demyelination and white matter necrosis in CNS tissue. The exact mechanism
of the late radiation damage onset in the CNS is not fully understood, but
vascular endothelial cells, oligodendrocytes and astrocytes have been implicated
in diffuse demyelination and necrosis following radiation exposure [15, 16]. It was
shown that vascular damage was responsible for the onset of late (7 months)
necrosis in the rat spinal cord [17-21]. In these studies, O-2A glial progenitor cells
survived selective vascular irradiation conditions, which indicated that vascular
radiation damage played a critical role in the onset of late radiation effects but
had no effect on the early radiation response in that system. Similar studies were
carried out in the rat brain where the loss of neural precursor cells was correlated
with stem cell dose and not the added dose selectively delivered to the
vasculature [22].
This same approach of selectively irradiating the vascular endothelium
should, in theory, be possible outside of the CNS, but would not be possible
using BSH. BSH has a molecular weight of only 350 daltons and has been
shown in previous boron-neutron capture therapy (BNCT) studies (where this
drug is primarily used) to uniformly equilibrate in non-CNS tissues [23]. In order
to develop a similar methodology for non-CNS tissues, a large 10B containing
compound must be used that is physically unable to diffuse out of the blood
stream through the capillary pores. Macromolecules migrate out of the blood
stream through the large-pore system of capillaries [24]. According to the pore
theory of capillary permeability, capillaries should allow the transmigration of
molecules of diameter up to ~500 A [24-26]. It has also been estimated that the
large-pore system occupies between 1-10% of the total pore surface area, which
also includes a system of small-pores with diameter ~90 A [24, 26]. Thus, the
objective is to choose a boronated molecule that has a larger average diameter
than the largest capillary pores.
Given the recent controversy surrounding the role of the vascular
endothelial apoptosis in the onset of the radiation-induced GI syndrome, this
tissue presented a good opportunity for a proof-of-principle study on the
development of a new methodology where we could selectively irradiate the
vascular endothelium in the mouse small intestine in a way similar to that already
carried out in the CNS. However, this would entail the development of a new
class of large boronated macromolecules. Chemists have already begun to
develop very large boron containing compounds for use in BNCT. We thought it
would then be fairly straight forward to adopt these boronated macromolecules
for use in the technique we wished to develop. The search for a sufficiently large
boronated molecule led us to the doctoral thesis work of Lars Gedda from
Uppsala University (1997) in Sweden. There, he studied and developed novel 10B
containing compounds for use in BNCT. Specifically, he developed large
boronated dextran molecules, which he then conjugated to epidermal growth
factor (EGF) to serve as a new BNCT agent against EGF receptor-rich tumors
such as gliomas, squamous cell carcinomas and breast cancers [27]. We were
able to reproduce the chemistry required to boronate dextran in large amounts,
but unfortunately, this molecule proved toxic to our mice during biodistribution
and crypt regeneration pilot studies. Large doses of dextran have been shown to
cause immediate histamine release in rats, which may be the cause of the acute
dextran toxicity [28-30]. Our search then led us to the BNCT compound
development efforts from the laboratory of M. Frederick Hawthorne of the
Department of Chemistry at UCLA (now at University of Missouri). There, he was
developing a new class of boronated compounds, which were subsequently
incorporated into liposomes [31, 32]. We were able to achieve very high 10B
concentrations in blood, with very low (undetectable) amounts in the surrounding
normal tissues. There was also no detectable mouse toxicity associated with the
boronated liposomes. These boronated liposomes now serve as the foundation
of the selective vascular irradiation studies that form the core of this project.
This chapter will serve to describe, in detail, the selective vascular
irradiation methodology from the development and characterization of a
sufficiently large 10B carrier through to its preliminary usage in mice. A careful
consideration of the associated vascular dosimetry will be made. Data from the
very first intestinal crypt regeneration and mouse survival studies using
boronated dextran will be presented, along with evidence for the dextran toxicity
in mice. Upon finishing the chapter, the reader should have a strong grasp of the
methodological details associated with the compound development, vascular
dosimetry and the crypt regeneration and mouse survival assays.
2.2 Materials and Methods
2.2.1 Boronated dextran synthesis
A large 10B enriched compound was developed for use in the selective
vascular irradiation experiments. The initial compound is a type of cross-linked
polysaccharide known as a dextran. Dextrans are high molecular weight
polysaccharides consisting of D-glucose subunits linked primarily through 1,6 a-
glycosidic bonds. The degree of cross-linking can be varied by the presence of
1,3 or 1,4 bonds. A dextran with a molecular weight of 77,000 daltons (Dextran
77, ~125 A), to which 40-50 BSH molecules have been covalently attached, has
been reported [27]. This dextran is similar in size to serum albumin (67,500
daltons), where one of its functions is the regulation of colloidal osmotic pressure
of blood. In fact, solutions of dextrans in the 70,000-75,000 dalton range have
been used as substitutes for blood plasma. The published procedure has been
used (although slightly modified) to produce boronated dextran (10B enriched)
(Figure 2-3) in large quantity. The complete procedure is as follows:
CH.
Figure 2-3. Final structure of boronated dextran after allylation at a hydroxyl group with
subsequent addition of BSH to the terminal double bond [27].
Allylation of Dextran
1. Set a water bath to 400C. Set a mineral-oil bath to 600C with constant
stirring to ensure proper thermal circulation. Allow the temperature to
stabilize.
2. Weigh out 2 g of Dextran 77, place in a 50 ml vessel and add 10 ml of
400C water. Leave in the 400C water bath.
3. Weigh out 0.5 g of NaOH (sodium hydroxide) in a 10 ml tube and add 5 ml
of 400C water. Leave in the 400C water bath.
4. Weigh out 20 mg of NaBH 4 (sodium borohydride) and keep in the
weighing boat/paper.
5. Add the NaOH solution and NaBH 4 to a reaction flask (50 ml, tear-drop or
round-bottom), washing the NaBH4off the boat.
6. Add the dextran solution to the reaction flask.
7. Add 2.5 ml of allyl bromide.
8. Add a stir bar, immerse the reaction flask in the 600C mineral-oil bath and
stir for 3 hrs.
9. When finished, pour solution into weighed beaker/flask and add 150 ml of
cold isopropanol. White precipitate will form (this is the allyl-dextran).
10. Leave in the refrigerator overnight.
11. Decant off the isopropanol.
12. Dissolve the precipitate in small amount (~ 5 ml) of warm water.
13. Add another 150 ml of cold isopropanol and leave in the refrigerator
overnight.
14. Decant off the isopropanol, and dissolve the precipitate again in a small
amount of warm water.
15. Add another 150 ml of cold isopropanol and leave in the refrigerator
overnight.
16. Lyophilize in weighed tube and store at -700C.
17. Weigh the tube to determine the amount of allyl-dextran present.
Boronating the Allyl-dextran
1. Add together 20 mg of 10B enriched sulhydryl boron hydride (BSH), 20 mg
of (NH4)2S208 (ammonium persulfate) and 20 mg of the allylated dextran
in 200 pl water.
2. Stir at 500 C for 2 hrs.
Purification (separation of boronated dextran from unbound BSH)
1. Use NAP-5 sephadex size-exclusion columns (Amersham Biosciences).
2. Add the 200 pl sample to the column. Allow the sample to fully enter the
column before proceeding.
3. Add 300 pl of distilled water. Allow this to fully enter the column before
proceeding.
4. Elute with 850 pl of distilled water and collect in a weighed container.
5. Lyophilize and store at -700C.
6. Weigh the tube to determine the amount of boronated dextran present.
Proton nuclear magnetic resonance (p-NMR) spectra were obtained to verify
the chemical structure of allyl-dextran. Since the addition of BSH to the terminal
double bond of the allyl-group is a fairly straight forward chemical reaction, the
positive identification of allyl-dextran was assumed to ultimately indicate that the
final product will be boronated dextran (Figure 2-4). These spectra were obtained
and analyzed at the Department of Chemistry's Instrumentation Facility (DCIF)
with the assistance of Sejal Patel (Ph.D. (2004), Department of Chemistry, MIT).
A saturated solution of allyl-dextran was made with NMR-grade heavy water
(D20). Spectra were obtained using a 500 MHz system, and samples were spun
to maintain magnetic field uniformity.
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Figure 2-4. p-NMR spectra on dextran or allyl-dextran. (A) Dextran alone shows no
signature in the allyl region. (B) Allyl-dextran exhibits the p-NMR allyl structure. The
handwritten numbers correspond to the specific location of each proton in the group.I-T  .S I ii •Figure 2-4. p-NMR spectra on dextran or allyl-dextran. (A) Dextran alone shows nosignatur in the allyl region. (B) Allyl-dextrn exhibits the p-NMR allyl structure. The
handwritten numbers correspond to the specific location of each proton in the group.
The solubility of the boronated dextran was high, which allowed the
injection of sufficient amounts of 10B for use in the selective vascular irradiation
studies. Boronated dextran was solubilized in phosphate buffered saline to a final
concentration between 20-80 mg boronated dextran/mi. Prompt gamma neutron
activation analysis (PGNAA, described in the next section) of a 20 mg/ml
boronated dextran solution indicated a 10B concentration of 2000 pg 10B/ml,
which means the boronated dextran contained approximately 100 pg 10B/mg.
This number agrees nearly exactly with Gedda [27].
2.2.2 10B Quantification: Prompt Gamma Neutron Activation Analysis
Neutron activation analysis (NAA) is a technique that has been developed
to determine the elemental composition of a material by measuring the decay
products emanating from the material after irradiation with neutrons. Each
elemental isotope has a characteristic decay signature. Therefore, the elemental
composition of a material can be ascertained by measuring this unique decay
signature. Prompt gamma neutron activation analysis (PGNAA) is a special case
of NAA where characteristic gamma rays are instantaneously emitted from the
sample following neutron activation and can thus be measured during the
neutron irradiation process.
PGNAA has been utilized to quantitate the amount or concentration of 10B
in a material. As described earlier, 10B will readily capture a thermal neutron and
spontaneously fission into two densely ionizing a and 7Li particles. The 7Li ion is
emitted in an excited state and will undergo subsequent relaxation to emit a 478
keV photon in 94% of decay events. This photon can then be used as the
characteristic decay signature for 10B [33]. The Nuclear Reactor Laboratory at
MIT operates a dedicated PGNAA facility on the 4DH3 thermal neutron port in
the MIT reactor. This facility was built and optimized for 10B quantification by Kent
Riley [34, 35]. In his method, a collimated thermal neutron beam is directed at a
sample containing an unknown quantity of 10B. Gamma rays emitted following
thermal neutron capture in hydrogen and 10B and are detected by a liquid
nitrogen-cooled high-purity germanium detector coupled to an appropriate
spectrometer. The system is calibrated by plotting the ratio of 10B to hydrogen
counts (B/H ratio) as a function of known 10B concentrations in liquid samples of
National Institutes of Standards and Technology (NIST) certified boric acid
(unenriched). Therefore, the 10B concentration in an unknown sample can be
easily calculated by measuring its B/H ratio. The practical detection limit of this
system is roughly 1 pg 10B/g in samples of only a few hundred milligrams.
2.2.3 Mouse*-Dextran biodistribution
Dextrans of varying molecular weight have been used to measure the
permeability of the rat intestine [24, 36], where electron microscopy was used to
* All animal procedures were reviewed and approved by the Committee on Animal Care at the
Massachusetts Institute of Technology and were conducted according to the principles outlined in
the Guide for the Care and Use of Laboratory Animals prepared by National Institute of
Laboratory Resources of the National Research Council.
visualize the location of individual dextran molecules after lead staining.
Individual 75,000 dalton dextran molecules were observed to pass through
fenestrae and channels of the endothelium and migrate to the pericapillary space
and the basement membrane, but the vast majority (initial plasma concentration)
remained in the blood vessel lumen. The 75,000 dalton dextran was still in the
blood plasma at 24 hrs post-injection. This study indicated that the leakage of the
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Figure 2-5. Mice (n=24) received 0.1 ml of a boronated dextran solution containing 8 mg
10B/ml via the retro-orbital sinus and were sacrificed at time points out to 90 minutes post-
injection. All of the individual values are shown.
Since the radiation dosimetry critically depends on the 10B concentration in
blood and tissue at the time of neutron irradiation, a mouse-dextran
biodistribution study was carried out to determine the 10B concentration in blood,
small intestine, liver, brain, muscle and skin as a function of time-post injection in
8-12 week old female BALB/c mice. Mice were briefly anesthetized under
isoflourane and injected with 0.1 ml of varying concentrations of boronated
dextran via the retro-orbital sinus. Mice were then humanely killed at various time
points post-injection, and various tissues were subsequently harvested for boron
analysis by PGNAA. Figure 2-5 shows the results of the biodistribution study
after a 0.1 ml injection of an 8 mg 1oB/ml boronated dextran solution.
Biodistribution studies in mice show a classic biphasic clearance pattern
with half-lives of roughly 10 and 60 minutes, respectively. The overall objective
was achieved with this compound in that very high blood-boron concentrations
(>150 ppm) were measured with relatively low boron concentrations (-30 ppm) in
the surrounding normal tissues. The data are completely consistent with the
presumed intravascular localization of the compound. Boron concentrations in
liver are considerably higher than the other normal tissues, which can be
attributed to the relatively high blood content in that particular organ [37]. The
liver also acts somewhat as a 'filter', which may also add to the high boron
concentrations observed.
The initial biodistribution experiments showed very high blood-boron
concentrations with long clearance half-lives, but the manner in which the mice
responded to the dextran injections foreshadowed the eventual failure of the
compound as a boron delivery agent. Preliminary vascular dose calculations (the
details of which will be covered later) indicated that in order to maximize the dose
delivered to vascular endothelial cells relative to the surrounding parenchymal
cells, a blood-boron concentration of >100 pg 10Bi/g at the time of irradiation was
desirable. Within the plateau region of the blood-boron clearance curve (Figure
2-5, >30 minutes), a 0.1 ml injection of the 8 mg 10B/ml boronated dextran
solution produced blood-boron concentrations in excess of 150 pg 10B/ml.
However, injection of boronated dextran at this concentration proved to be too
toxic for the mice and would not be suitable for longer term experiments: 5/5
mice died within 24 hours. This small survival experiment was performed in
response to obvious acute toxicities (shallow, rapid breathing, delay in coming
out of anesthesia) during the biodistribution experiments. Subsequent injections
of boronated dextran, diluted to 4 mg 10B/ml, resulted in the deaths of 2/5 mice
within 24 hours. The remaining survivors lost 20% of their body weight within a 3
day period. Even further dilution to 2 mg 10B/ml yielded a better mouse response:
all mice survived with minimal weight loss. At this dilution, a biodistribution study
and PGNAA boron analysis showed 41.6 ± 11.3, 37.1 ± 6.2, 7.1 + 2.7, 2.2 ± 0.5
and 3.9 ± 0.9 pg 10B/g in blood, liver, small intestine, muscle and skin,
respectively, at 30 min post-injection. The boron content in the brain was below
the detection limit for the PGNAA system. These concentrations were sub-
optimal, but were ultimately used for the subsequent intestinal crypt regeneration
and mouse survival studies in order to avoid unwanted mouse deaths due to the
dextran toxicities at higher concentrations. Due to logistical reasons associated
with the neutron irradiations along with the behavior of the blood-boron clearance
curve, 30 minutes post-injection was chosen as the starting point for the
irradiations.
2.2.4 Neutron irradiation, crypt regeneration and mouse survival
2.2.4.1 Neutron irradiation facilities
The fission converter neutron beam (FCB) irradiation facility at the MIT
reactor is a state-of-the-art irradiation facility, which has been optimized for
human irradiations during cancer treatment using boron neutron capture therapy
(BNCT) [38-40]. A specific mouse irradiation geometry (described later) has been
developed to allow uniform neutron penetration, which is optimal for these
studies. Neutrons are delivered at epithermal energy (average energy 2 keV) to
maximize beam penetration into tissue. The thermal neutron flux peaks inside the
mouse after neutron thermalization (energy loss via collission) during passage
through Lucite shielding material and mouse tissue. This results in a uniform
dose distribution as a function of depth through the mouse body. Whole-body
irradiations are possible, because the endpoints in the following studies are short
compared to the onset of the bone marrow and gastrointestinal radiation
syndromes. The facility is equipped with an automated dose monitoring and
control system to precisely administer the desired dose.
2.2.4.2 Epithermal neutron beam dosimetry
Whole-body mouse irradiations were carried out in the epithermal neutron
beam at the MIT reactor (MITR) as previously described [41]. Mice were
irradiated in a Lucite holder designed to immobilize unanesthetized mice by all
four feet such that the abdomens were presented to the 16-cm-diameter
horizontal epithermal beam [41]. Unless specifically noted, all doses quoted are
physical absorbed doses to which no weighting factors have been applied.
Absorbed doses ranging from 3.2 ± 0.2 to 10.0 + 0.7 Gy were administered with
irradiations lasting from 6 to 20 min. The epithermal neutrons were thermalized
by 1.5 cm of Lucite, consisting of the 0.5 cm thick mouse holder and an
additional 1.0 cm sheet of Lucite placed between the holder and the beam
aperture. The mouse bodies were centered at a depth of 2.5 cm. Photon and fast
neutron absorbed dose rates were measured using paired ionization chambers
with walls of graphite and tissue equivalent A-150 plastic. The absorbed dose
from neutron capture in 10B and nitrogen was determined using the measured
difference in the activation of bare and Cd-covered gold foils and kerma
coefficients of 8.66 x 10-8 and 7.88 x 10-12 Gy cm2, respectively. A uniform
nitrogen concentration of 3.5% by weight was applied for tissue and boron
concentrations measured in the biodistribution studies were used to determine
the absorbed doses in the blood and vessel wall [38].
The total absorbed dose rate in the epithermal neutron beam was 0.57 +
0.04 Gy min-' at a depth of 2.5 cm and was comprised of 77% low-linear energy
transfer (LET) photons and 23% high-LET radiations, which are principally
protons arising from thermal neutron capture in nitrogen. The relative uncertainty
on the neutron beam doses was 2.2%, which includes only the statistical
uncertainty in the beam monitor counts and variations of approximately 1 mm in
positioning of the irradiation jig along the center of the beam central axis. The
additional absorbed dose rate from the 10B capture reactions was 3.3 ± 0.18 cGy
min 1-' per ig 10B present.
2.2.4.3 Selective vascular irradiation dosimetry
The boron neutron capture reactions in the boronated dextran groups
occur, by design, only within the vessel lumen. This creates a non-uniform dose
distribution in which the dose delivered to the vascular endothelium is less than
the boron dose absorbed in the blood volume within the lumen. Rydin et al.
quantified this effect of vessel geometry on the dose absorbed in an endothelial
cell from boron neutron capture reactions restricted to the lumen of a blood-filled
capillary relative to the boron dose absorbed in the blood [42]. According to this
model, when 10B is restricted to the lumen, the boron dose absorbed in the
capillary wall is 1/3 of the boron dose absorbed in the blood, given a capillary
wall thickness of 0.25 tm, which is considered representative for the mice used
in this study. The total physical absorbed dose in the vascular endothelium is the
sum of the external beam dose and the vascular-specific boron dose. The
vascular-specific boron dose is calculated as:
Dv = (1/3) ((8.66 x 10-12 cGy cm2/ppm))( 10B [ppm]))
(D = Thermal neutron flux [(cm2 S)-1]
The total absorbed dose rate in the vascular endothelial cells, with
boronated dextran in the blood at the time of neutron irradiation, was estimated
as the sum of the whole-body neutron beam absorbed dose rate plus 1/3* of the
10B absorbed dose rate in the blood. The additional absorbed dose rate in the
microvasculature coming from boron neutron capture reactions in the blood was
1.1 ± 0.06 cGy min-' per pýg 10B, which includes the geometrical factor of 1/3 [42].
The higher 10B concentration in the blood associated with the boronated dextran
allowed the dose to the vascular endothelial cells to be increased, while holding
all other parameters constant. Thus, the total absorbed dose rate in the
microvasculature was 1.01 ± 0.05 Gy min 1-' (a factor of 1.8 greater than the
neutron beam dose) with a boron concentration of 42 ± 11 pg 10Bi/g in the blood.
The stated uncertainties on the microvascular absorbed dose rates include the
uncertainty in the neutron beam dosimetry as well as the uncertainty in the blood-
boron concentration at the time of irradiation. The calculated dose separation is
shown in Figure 2-6.
* n.b. - This geometrical factor of 1/3 will range from 1/3-1/5 depending on variations in capillary
size (diameter and wall thickness). Even if a factor of 1/5 is used in the vessel dose calculations,
the resulting vessel doses are still high enough so as not to affect any of the conclusions
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Figure 2-6. Calculated doses delivered to the crypts (neutron beam-only, closed circles)
and the vascular endothelial cells (open circles). The line separation demonstrates the
concomitant vascular dose associated with the external neutron beam dose with
boronated dextran in the blood. The dose rate to the vasculature is 1.8 times the dose rate
to the crypts.
2.2.4.4 Intestinal crypt regeneration assay
The intestinal crypt regeneration assay was used to measure the effect of
radiation exposure on the survival of intestinal crypt stem cells. Mice were
irradiated with either the neutron beam alone, or after a 0.1 ml retro-orbital
injection of a 2 mg 10B/ml boronated dextran solution, to doses from 0-10 Gy.
Mice were then sacrificed 84 ± 1 hrs (3.5 days) after irradiation by asphyxiation in
a carbon dioxide atmosphere or inhalation overdose of isoflourane. The mouse
abdomen was neatly dissected to fully expose the digestive tract. The small
intestine was carefully removed so as not to damage the delicate tissue. A 5 cm
section of the jejunum (middle 5 cm of the middle third of the small intestine
measured from stomach to caecum) was ultimately harvested. The gut contents
were carefully expressed, and the lumen was washed with a 10% formalin
solution with the careful use of a syringe and needle. The segment of jejunum
was then further cut into approximately ten 0.5 cm segments, immersed in 10%
formalin fixative for 24-48 hours and processed for histology' by embedding the
sections vertically in paraffin to generate circular cross sections when cut.
Sections (3-6 pm thick) were taken from the paraffin tissue blocks. They were de-
paraffinized and stained with hematoxilin & eosin (H&E) to reveal the tissue
structure. Stained tissue slides were visualized under a visible light microscope
using 100-400X magnification to clearly show the structure of regenerating crypts.
The criteria used for scoring a regenerating crypt were 10 or more contiguous
epithelial cells and at least one viable Paneth cell [43-45]. No size correction
factor was applied as the average crypt size in all irradiation groups was the
same [46]. All slides were scored by a single, blinded observer.
* Most paraffin embedding and tissue staining in this project was performed in the histology
laboratory of MIT's Division of Comparative Medicine by Kathleen Cormier under the advisement
of Prashant Nambiar, PhD (no longer at MIT) or Arlin Rogers, PhD (current DCM pathologist).
Histology work was also carried out at an outside laboratory, MassHistology (Worcester, MA), as
needed.
The numbers of regenerating crypts as a function of neutron beam dose
are plotted in Figure 2-7. The neutron beam-only crypt regeneration data are in
good agreement with the results of Gueulette et al. [47] in the same mouse
(female BALB/c) using the same irradiation jig and geometry in the same
epithermal neutron beam. The neutron beam plus boronated dextran line is
shifted to the left relative to the neutron beam-only line. This implies that there
was enhanced crypt death per unit neutron beam dose due to the presence of
the boronated dextran in the blood. The additional dose selectively delivered to
the vasculature thus resulted in enhanced crypt death. This strongly suggested
that radiation damage in the vascular endothelial cells contributed to stem cell
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Figure 2-7. Crypt regeneration as a function of neutron beam dose for neutron beam-only
or neutron + boronated dextran irradiations. The neutron beam + boronated dextran line is
shifted to the left, which implies that vascular damage plays a role in the radiation-induced
GI syndrome. Four mice per point, 4 intestinal cross-sections scored per mouse.
2.2.4.5 Mouse survival following whole-body neutron irradiation
A mouse survival endpoint was used to determine the mode of death
following whole-body neutron beam irradiation either alone or in the presence of
boronated dextran only in the blood (0.1 ml retro-orbital injection of a 2 mg 10B/ml
boronated dextran solution). The objective of this study was to bring the neutron
beam dose right up to the transition from a bone marrow to a GI syndrome
induced death and then selectively add dose to the vasculature to see if the
mode of death changed from the bone marrow syndrome to the GI syndrome. In
mice, the GI syndrome will occur within 4-5 days following large doses (>13 Gy
photons), whereas the bone marrow syndrome will occur within 7-14 days
following lower radiation doses. If the transition were to occur, it could be
concluded that vascular damage plays a critical role in the radiation-induced GI
syndrome.
Groups of 11-13 female BALB/c mice received whole-body neutron beam
doses of 8.3 Gy in the presence or absence of boronated dextran in the blood.
Mice were allowed to live beyond the usual 3.5 day endpoint for the crypt
regeneration assay to allow the various radiation syndromes time to develop.
Mice were monitored daily for overall health and were sacrificed upon entering a
moribund state. One must be diligent in performing such experiments, as the
mouse must be sacrificed right before it dies to both obtain a valid data point and
avoid any undo pain and suffering for the animal. A plot of percent survival
versus number of days post-irradiation is shown in Figure 2-8. It is clear that the
group that received neutron irradiation with boronated dextran in the blood,
















Figure 2-8. Mouse survival after whole-body neutron beam irradiation (8.3 Gy) in the
presence or absence of boronated dextran in the blood.
Time of death is often times insufficient to determine the exact cause of
death. We know from classical radiation biology experiments that the time of
death due to the GI syndrome can be affected by the intrinsic radio-sensitivity of
the hematopoietic bone marrow cells [48]. Mason et al. showed that intestinal
stem cell survival was the same in mice that received either whole-body
0
irradiation or just abdominal irradiation. However, the LDs50 (lethal dose in 50% of
the population) shifted from -20 Gy to ~16 Gy when the irradiation conditions
were changed from total abdominal to whole-body irradiation conditions. Thus,
the LD50o was shifted by ~ 4 Gy, which can be attributed to the influence of bone
marrow sensitivity on time of death. Therefore, animal survival after large
radiation doses is not solely related to intestinal stem cell survival but, rather,
depends on the combined influence of both intestinal and hematopoietic stem
cell sensitivities [48].
Femur and small intestine samples were harvested from the mice at the
point of sacrifice and were subsequently prepared for histology. Femurs were
decalcified in a formic acid and 10% formalin solution for 12-24 hrs, after which
they were immediately transferred to a 10% formalin fixation solution. Femurs
were then embedded in paraffin in a horizontal fashion to reveal the bone marrow
when cut. Longitudinal sections (3-6 pm think) were taken from the paraffin tissue
blocks and stained with H&E to reveal the bone and bone marrow structure.
Small intestine samples were harvested and prepared in an identical manner to
what has already been described in Section 2.2.4.4. Histological images from the
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Figure 2-9. Representative H&E stained small intestine and bone marrow sections from
mice that received epithermal neutron beam irradiation in the presence or absence of
boronated dextran in the blood. The top row of images was taken from a mouse sacrificed
9 days after neutron irradiation. The bottom row of images was taken from a mouse
sacrificed 4 days after a neutron beam dose of 8.3 Gy with boronated dextran in the blood
(blood vessel dose = 15 Gy). Scale bars = 100 pm.
Figure 2-9 clearly shows the mode of death for animals subjected to each
irradiation condition (neutron beam-only or neutrons + boronated dextran in the
blood) in the animal survival experiments. It was determined from these
experiments that the transition point for death from the bone marrow syndrome to
the GI syndrome occurs between 8.3 - 9.0 Gy (neutron beam-only dose; see
Figure 3-4). Therefore, the images in the top row of Figure 2-9 show a mouse
that was given a dose very close to this transition point. It is clear from the
I Bone Marrow I
histology that this mouse died from the radiation-induced bone-marrow syndrome,
as the gut was well on the way to recovery while the bone marrow was severely
depleted and showed extensive necrosis of the matrix with widespread
hemorrhaging. In contrast, the images in the bottom row of Figure 2-9 are from a
mouse uniformly irradiated to the same dose as the mouse in the top row (8.3
Gy) but with a substantially higher dose delivered to the microvasculature from
the boronated dextran restricted to the blood stream. This mouse obviously died
of the GI syndrome. One can see that the familiar crypt-villus structure of the
small intestine was completely destroyed. As a result, this mouse could no longer
absorb nutrients from the intestinal lumen and probably died from a bacterial
infection due to the invading gut microflora. Even though the bone marrow from
this mouse was also severely depleted, this mouse ultimately succumbed to the
GI syndrome, as a GI syndrome induced death will occur more rapidly than a
bone marrow syndrome induced death. Therefore, it seemed evident at the time
that radiation damage in the vascular endothelium was playing a critical role in
the development of the radiation-induced GI syndrome, because the added dose
selectively delivered to the vascular endothelium from the boronated dextran was
able to cause a transition in the mode of death from the bone marrow syndrome
to the GI syndrome.
2.2.4.6 Selective vascular irradiation dosimetry revisited
One potential concern that arose during the course of developing the
selective vascular irradiation methodology was the potential for direct crypt
irradiation from a-particles coming from the blood vessels adjacent to the crypts.
The 9 pm range of the alpha particle released from the boron neutron capture
reaction is sufficient to reach and kill crypt stem cells if the blood vessel is within
9 pm of a crypt. It was believed at the time that, if this were to occur, the added
crypt dose due to direct a-particle irradiation would be negligible compared to the
neutron beam dose and would not cause enhanced stem cell death.
Nevertheless, more quantitative studies were needed to ensure that any
observed physiological change was due to the dose to the vasculature and not
the potential added dose from a-particles escaping from within blood vessels.
Figure 2-10 shows staining for a vascular specific marker, CD31, used to
visualize the complex network of blood vessels around crypts. CD31 plays an
important role in tissue regeneration and is typically expressed on endothelial
cells, platelets, lymphocytes and neutrophils among other cell types.
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Figure 2-10. CD31 staining for blood vessels (brown) with a hematoxylin counterstain
(blue). Scale bar = 25 pm.
Three qualitative arguments were initially made to show how any direct a-
particle irradiation of crypts would have a negligible effect on the overall
physiological response when compared to the neutron beam doses delivered
during the selective vascular irradiation experiments. They are: 1) The spatial
relationship between intestinal crypts and blood vessels in CD31 stained sections
(cf. Figure 2-10) was measured. Of 515 crypts counted, 60% had a blood vessel
within ~10 pm. 2) Particles emitted from boron neutron capture reactions in the
blood will have an isotropic distribution in space. The available surface area
(solid angle) for a-particle interaction on the crypt surface will be small. Thus,
only a small percentage of those a-particles released beyond the lumen of the
blood vessel will contribute to the overall crypt dose. 3) The exact positions of the
stem cells within a crypt are still unknown, although labeling studies indicate that
cell positions 4-5 probably contain the regenerative stem cells [45]. It is also
necessary to keep in mind that intestinal crypts are three dimensional structures.
Crypts contain 16 cells assembled into an annulus at each position [49]. Thus, in
order to completely inactivate a crypt's proliferative capacity, all 48 cells at
positions 4-6 must be killed. Since there will only be a few crypt cells within 9 pm
of a blood vessel, the probability of killing all of the cells in the annulus subtended
by postitions 4-6 is very low. These arguments were supplemented by more








Figure 2-11. Input geometry for an endothelial cell used to calculate the a-particle dose
gradient beyond the vessel lumen [53].
Extensive quantitative studies have already been performed to address
the problem of vascular dose during BNCT or use of intravascular radiation
sources [14, 50-54]. Specifically, various computational techniques were
developed to quantify absorbed dose in endothelial cells during BNCT [52, 53]. A
Monte Carlo based particle tracking program was developed by David E.
Charlton et al. [52, 53] to quantify the dose to an endothelial cell nucleus for the
various I0B distributions typically seen in BNCT. This program was obtained from
D. E. Charlton by personal request. Charlton's program proved useful, because
the input parameters that defined the cell geometry could be manipulated to
allow one to restrict 10B to the vessel lumen and vary the capillary size, which
would perfectly model the unique 10B distribution and dosimetry problems in this
project.
The program uses the standard Monte Carlo technique where the origins
of ions produced by the boron neutron capture reactions are placed at random
within an interaction volume, which in this case is the blood vessel lumen (Figure
2-11). As the source ions will be emitted isotropically, their angular directions can
be determined using Monte Carlo methods [53]. To determine if an ion will
traverse the endothelial cell nucleus, the simultaneous equations are solved for
the ion track and nuclear surface, which are given by:
Ion Track: (x-xi)/cos a = (y-yl)/cos / = (z-zi)/cos y
(where xi, yi, zi are the coordinates for the ion's origin; a, 13, y are the directional
angles; x, y, z are the track coordinates)
Nuclear Surface: (x2/a2)+ [(y-(x 2/w2))2/b2] + (z2/c2) = 1
(where a,b,c are ellipsoidal radii, and w is an adjustable parameter to control the
nuclear curvature)
To calculate the a-particle dose gradient as a function of distance from the
edge of the blood vessel lumen, the input parameters used to define the
geometry of the endothelial cell were adjusted such that the endothelial cell
nucleus could be moved at defined intervals away from the vessel lumen and
used as a dosimeter. By keeping the lumen dimensions constant, increasing the
thickness of the capillary wall to 8pm, and moving the cell nucleus from the edge
of the lumen to the outer wall in small increments, it became possible to use the
absorbed dose to the nucleus as an indicator of the dose gradient as a function
of distance from the vessel lumen. The simulation was run to mimic the highest
neutron beam dose delivered in the selective vascular irradiation studies, which
would serve as an upper limit for the a-particle dose gradient outside of the
vessel lumen. The specific input data are shown in Table 2-1 below:
Table 2-1: Simulation Input
Nuclear radii (pm): 1.
Radii of lumen (pm):
Radius of capillary (pm)
Distance from nucleus to lumen:
Distance from nucleus to outer wall:
Distortion factor (w):



























Running the simulation was a fairly straight forward process. The specific steps
taken in the running of these simulations are outlined in Table 2-2 below:
Table 2-2: Mechanics of the Simulations
* Keep the lumen dimensions constant.
* Keep [10B] in lumen constant.
* Keep the neutron fluence constant.
* Keep the nuclear dimensions constant.
* Increase the capillary wall thickness to 8 pm
* Vary the nucleus-to-lumen distance (0.0, 0.2, 0.5,
1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 pm).
* Run the simulation to calculate the absorbed dose
in the nucleus as a function of distance from the
vessel lumen.
The results of the dose gradient simulations are shown in Figure 2-12 below:
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Figure 2-12. a-particle dose as a function of distance from the vessel lumen.
The dose gradient shown in Figure 2-12 shows a nearly 1/r2 behavior as
the distance between the nucleus and vessel lumen was steadily increased. At a
distance of just 2 pm from the vessel lumen, the dose was only 25% of the dose
at the luminal wall, and at a distance of just 7 pm from the vessel lumen, the
dose was nearly zero. Thus, these quantitative calculations coupled with the
qualitative arguments outlined above led to the ultimate conclusion that the a-
particle dose contribution to the crypt stem cells was negligible, and that the
probability of all cells in the proliferative annulus subtended by positions 4-6
receiving a lethal dose from particles originating within the vessel lumen was
vanishingly small.
2.3 Discussion: failure of dextran, transition to liposomes
The ultimate objective of this period in the project was to find a 10B
delivery agent that could supply sufficiently large blood-boron concentrations
(>100 ppm) at the time of neutron irradiation (30 min post-injection) without
leaking from the vasculature or being overtly toxic. Boronated dextran could
satisfy the requirement to deliver sufficiently large blood-boron concentrations,
but it failed from the standpoint of its overt mouse toxicity and possible leakage
due to this inherent toxicity (increased vascular permeability following
anaphylaxis reactions). The 8 mg 10B/ml injection solution of boronated dextran
was able to supply blood-boron concentrations in excess of 150 ppm at 30 min
post-injection, but the mice did not survive longer than 24 hrs. To cope with this
undesired toxicity, the injection solution concentration had to be reduced to a
point where the mice could tolerate it; this concentration was ultimately 2 mg
10B/ml. Because of this compromise, the blood-boron concentration 30 min post-
injection fell from >150 ppm to ~ 40 ppm. This low blood-boron concentration
would not be sufficient to achieve the desired dose separation (ideally a factor of
3 greater than the neutron beam dose) between the whole-body epithermal
neutron beam dose and the concomitant vascular dose. All of the data presented
in this chapter were gathered using an injection solution concentration of 2 mg
10B/ml. Although it seemed from the data gathered using boronated dextran that
the vasculature played a role in intestinal crypt stem cell death and the eventual
development of the radiation-induced GI syndrome, the overt dextran toxicity led
us to question the validity of our data. What effect could dextran have on
vascular permeability? Can we be sure that the dextran is not leaking? Are the
observed effects in the crypt regeneration and animal survival assays due to
damage to the vasculature or boronated dextran leakage out of the blood into the
surrounding tissues? These questions could not readily be answered. At that
point, the possible conclusions one could draw from the data were tenuous at
best.
A search of the literature revealed that high concentrations of dextran
administered to rats or isolated mast cells cause a massive histamine release,
and in the case of the in vivo rat studies, high doses of dextran ultimately led to
anaphylactic edema [28-30]. Edema is defined as the increased secretion of fluid
into the tissue interstitium or impaired fluid removal causing tissue swelling. The
rat experiments showed an increase in anaphylactic edema in the foot and skin
following localized dextran injections in the respective tissues. The conclusions
from these studies could explain the acute boronated dextran toxicity observed in
the mice at the higher injection concentrations given systemically. The most
pertinant study, however, was from Haraldsson et al. where they were able to
show that histamine release increases capillary permeability in a calcium-
dependent manner [55]. A possible sequence of events leading to animal toxicity
could be that the high systemic doses of dextran caused massive histamine
release leading to increased capillary permeability and subsequent lethal
anaphylactic edema. The lower dextran injection doses could potentially avoid
lethal anaphylactic reactions but still maintain increased vascular permeability.
Therefore, one could suspect that the observed effects in the crypt regeneration
and mouse survival assays were the result of boronated dextran leakage from
blood vessels and not the result of vascular damage. The added boron dose to
the intestinal crypts from the leakage of boronated dextran out of the blood could
cause both the enhanced crypt death seen in the crypt regeneration assay
(Figure 2-7) and the transition from a bone marrow syndrome induced death to a
GI syndrome induced death as seen in the mouse survival assay (Figures 2-8 &
2-9). Because of both the animal toxicity and possibility of boron leakage
associated with the boronated dextran, a new, more reliable compound was
needed that would allow us to escape most of these pressing questions.
When the validity of boronated dextran came into question, a collaboration
was established with M.F. Hawthorne of the Department of Chemistry and
Biochemistry at UCLA (now at University of Missouri), a leading authority on
boron chemistry. The Hawthorne group has been developing novel 10B
containing compounds for use in BNCT for many years. They have developed a
set of novel boron compounds that can be readily incorporated into liposomes
[31, 32]. Figure 2-13 shows both of the new boron compounds that have been
developed as well as a schematic picture of a liposome. Liposomes with the




















Figure 2-13. Liposomes have been prepared with the boronated compounds, MAC and
TAC, incorporated into the lipid bilayer and aqueous core, respectively. DSPC =
distearoylphosphatidylcholine.
embedded in the lipid bilayer have been prepared [32] as well as liposomes with
the water-soluble polyhedral borane anion derivative [B20H17NH3]3 (TAC)
dissolved in the aqueous core [31]. Liposomes with MAC in the lipid bilayer and
TAC in the aqueous core have also been prepared [56].
Liposomes 69 nm in diameter with MAC incorporated into the lipid bilayer
were prepared by the Hawthorne group and sent to the Coderre group. This was
the first batch' of liposomes tested by the Coderre group. Boron analysis of the
MAC liposome preparation using PGNAA yielded an initial 10B concentration of
260 pg 10B/ml. It was determined that the mice could endure a retro-orbital
injection volume of 0.2 ml, which delivered an injected 10B dose of 2.6 mg "oB/kg
body weight. For an initial MAC liposome biodistribution study, 10 female BALB/c
mice were each injected with 0.2 ml of the liposome solution via the retro-orbital
sinus and were then sacrificed 30 minutes post-injection for boron analysis using
PGNAA. The blood-boron concentration at 30 minutes post-injection was 32.5 ±
3.5 pg 10B/g (mean ± SD). This blood-boron concentration is consistent with
complete intravascular localization of the MAC liposomes. Assuming the blood
content in a mouse is -7% of its body weight, the injected boron dose would
result in a theoretical blood-boron concentration of ~ 35 pg 10B/g. More proof of
complete intravascular localization of the MAC liposomes came from the gross
10B concentration in the small intestine. The boron concentration in the small
intestine at 30 minutes post-injection was actually below the detection limit for the
prompt gamma neutron activation analysis system. Fluorescently labeled
(Rhodamine-DHPE) liposomes (MAC, unenriched) were also used to show
complete vascular localization in tissue (Figure 2-14). The 10B concentration in
4 n.b. - Subsequent batches of boronated liposomes had slightly different average diameters and
10B concentrations. Independent boron analyses and biodistribution studies were performed for
each batch (e.g., Chapter 3 uses a different batch and presents different biodistribution data).
liver was ~ 8 pg 10B/g, which was anticipated due to the high blood content of
liver. There was no apparent mouse toxicity associated with any of the injections





Figure 2-14. Visible light image (left) of an unstained frozen section (10 pm thick) of a
mouse villus (grey) superimposed on a fluorescence image (red) of the same villus
following a 0.2 ml retro-orbital injection of fluorescently labeled lipsomes. An adjacent
fluorescent villus without visible light overlay is shown on the left side of the image.
Fluorescence image (red) of the liver from the same mouse (right). Complete vascular
localization of the liposomes is suggested in the small intestine (left, intense fluorescence
in the region of high vascular density). Intense fluorescence in the liver is due to very high
vascular density (right).
The initial biodistribution studies using the MAC liposome solution were
intended to quickly ascertain whether there was any apparent boron leakage or
acute mouse toxicity. However, the MAC liposome solution produced a relatively
low blood-boron concentration (roughly the same as boronated dextran) and
would not be sufficient for further radio-biological studies. Thus, a liposome
formulation with a much higher 10B concentration was needed. Liposomes 75 nm
in diameter with MAC in the lipid bilayer and TAC in the aqueous interior were
prepared by the Hawthorne group and sent to the Coderre group. This liposome
solution contained 1482 pg 1oB/ml as determined by PGNAA, and a 0.2 ml
injection volume delivered an injected 10B dose of 14.8 mg 10B /kg body weight.
Twenty four female BALB/c mice were injected with 0.2 ml of the MAC+TAC
liposome solution via the retro-orbital sinus for biodistribution and animal toxicity
studies. At 30 minutes post-injection the blood-boron concentration was 127 ± 25
pg 10B/g (n=9). Between 60 and 90 minutes post-injection, the blood-boron
concentration was 108 ± 14 pg 10B/g (n=10). For all time-points the 10B
concentrations in small intestine and skin were below the PGNAA detection limit,
which was indicative of complete intravascular localization of the liposomes.
Boron concentrations in liver were ~ 80 pg 10B/g. Finally, the 0.2 ml MAC+TAC
injection volume produced no apparent toxic side effects as judged by body
weight and condition over a 1 week period (n=5).
Very high blood-boron concentrations with no apparent mouse toxicities
were thus achievable with the new MAC+TAC liposome formulations. Blood-
boron concentrations of 127 ± 25 pg 10B/g allowed the dose absorbed in the
microvasculature to be increased by a factor of >3 relative to the concomitant
neutron beam dose delivered to the rest of the body (crypt stem cells in
particular). Thus, the epithermal neutron beam dose could be maintained well
below the threshold for detectable crypt depletion of ~ 5-6 Gy, while also
simultaneously delivering a dose to endothelial cells well above this threshold.
Thus, the objective of adequate dose separation between the neutron beam dose
and the simultaneous dose to the vasculature was achieved with no detectable
mouse toxicity using the liposome solutions. These liposome formulations served
as the foundation of the radio-biological studies that form the core of this thesis,
which will be described in detail in the following chapters.
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Chapter 3: Selective Irradiation of the Vascular
Endothelium has no Effect on the Survival of Murine
Intestinal Crypt Stem Cells*
3.1 Introduction
Radiation-induced changes seen in normal tissues are traditionally
separated into early and late effects. Stem cell-based, rapidly-renewing normal
tissues such as the bone marrow and the intestinal epithelium are early-
responding tissues where the time courses of the radiation syndromes are
directly related to the turnover time of the differentiated functional cell
compartments. The intestinal stem cells reside in the crypts of LieberkOhn at the
base of the finger-like villi that comprise the intestinal epithelium. Epithelial cells
differentiate as they migrate up the crypt and the villus and are eventually
sloughed off at the tip into the intestinal lumen: the transit time taking
approximately 3-4 days. In the mouse small intestine, a wave of apoptosis is
observed, in what are thought to be crypt stem cells [1], as early as 3-6 hrs after
irradiation with doses as low as 0.01 Gy [2]. This effect saturates at about 1 Gy.
Higher doses are postulated to deplete the first few generations of differentiated
transit cells that still retain the ability to revert to fully-functional stem cells [2].
Individual crypts are not sterilized until all of the actual and potential stem cells
* Schuller, B.W., P.J. Binns, K.J. Riley, L. Ma, M.F. Hawthorne, and J.A. Coderre, Selective
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are inactivated, which occurs at doses of about 8 Gy or higher. The crypt
microcolony assay measures the survival of the last individual potential stem
cells within each crypt [3]. This assay involves counting the number of
regenerating crypt-like foci per intestinal circumference at 3-4 days post-
irradiation. The survival of one or more clonogenic cells per crypt allows its
regeneration. Doses above approximately 15 Gy sterilize virtually all of the crypt
stem cells, resulting in complete loss of the intestinal villi and death from the GI
syndrome in about 4-5 days. It has traditionally been assumed that the
gastrointestinal (GI) syndrome results from the direct killing of the rapidly growing
stem cells, depletion of the differentiated parenchymal cells and subsequent loss
of tissue function [2, 4].
The GI syndrome has, however, recently been suggested to be a direct
consequence of an early (4 hrs) wave of apoptosis in the intestinal vascular
endothelial cells [5]. These authors irradiated mice with single whole-body photon
doses of 15 Gy, sufficient to cause death from the GI syndrome, and
demonstrated that it was possible to change the mode of death from the GI
syndrome to the bone marrow syndrome (in effect, producing about 3 Gy of
radioprotection) when endothelial cell apoptosis was suppressed genetically by
deletion of the gene for acid sphingomyelinase, which controls endothelial cell
apoptosis through a ceramide pathway, or pharmacologically by administration of
basic fibroblast growth factor. The precise mechanism of this proposed linkage
between intestinal endothelial cell apoptosis and crypt stem cell depletion leading
to the GI syndrome remains unproven [6-8].
An approach for the selective irradiation of the vascular endothelium that
allows mechanistic studies into the role of endothelial cell damage in normal
tissue radiation responses [9-12] has been applied in this report to crypt stem cell
loss in the mouse small intestine. The method is based on the short-ranged (5-9
gm) alpha and lithium particles released from the neutron capture reaction in the
stable minor isotope of boron: 10B. When the 10B was restricted to the blood by
incorporation into liposomes that could not diffuse into the surrounding tissues,
absorbed dose in the microvasculature was increased relative to the uniform
dose delivered by the neutron beam to the rest of the body. It is reported here
that for both intestinal crypt stem cell survival and mode of death, there were no
differences between the groups that were irradiated with the neutron beam alone
and those that received the same beam dose and a substantially higher dose
selectively delivered to the microvasculature.
3.2 Materials and Methods
3.2.1 Boron analysis
The boron concentration in liquid or solid samples was determined using
the prompt gamma neutron activation analysis (PGNAA) facility at the MIT
reactor [13]. This spectroscopic technique measures the prompt gamma ray
emitted by the recoiling 7Li nucleus following neutron capture in 10B using a high
purity germanium detector. The system was calibrated using National Institute of
Standards and Technology (NIST) certified boric acid, and has a detection limit of
approximately 1 pg for 10B. All stated uncertainties on 10B measurements
represent 1 standard deviation.
3.2.2 Liposomes
Two different 10B-containing liposome formulations were used for these
studies. Liposomes containing the amphipathic nido-carborane anion species, K'
[nido-7-CH3(CH2)15-7,8-C2B9 Hll]1- (MAC), embedded in the lipid bilayer were
prepared as previously described [14]. The water-soluble [B20H17NH3]3- (TAC)
polyhedral borane anion derivative can be incorporated into the interior of the
liposome [15]. Liposomes with MAC in the lipid bilayer and TAC in the interior
(MAC+TAC) were prepared as described [16]. All boron compounds were
enriched in the 10B isotope to >98%. The liposome formulations had a mean
vesicle diameter between 70 and 90 nm and contained 24 mg total lipid/ml. The
MAC and the MAC+TAC liposome injection solutions were sterilized by passage
through a 0.22 pm filter before use and contained 540 ± 27 gg 10B/ml and 1580 ±
79 pýg 10B/ml, respectively.
3.2.3 Animals and animal procedures
Female BALB/c mice, 8-12 weeks of age, were maintained in a 12-hour
light/dark cycle and given food and water ad libitum. All procedures were
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reviewed and approved by the Committee on Animal Care at the Massachusetts
Institute of Technology and were conducted according to the principles outlined
in the Guide for the Care and Use of Laboratory Animals prepared by the
Institute of Laboratory Animal Resources, National Research Council.
3.2.4 Biodistribution studies
The 10B dose distribution is directly related to the 10B concentrations in
tissues at the time of irradiation. Liposome biodistribution studies were carried
out to determine the amount of 10B in blood, liver, skin and small intestine as a
function of time post-injection. Twenty BALB/c mice were injected with 0.2 ml of
the MAC liposome solution (108 tg 10B) via the retro orbital sinus while under
brief isofluorane anesthesia. Five mice were killed by inhalation overdose of
either isofluorane or carbon dioxide at each of 4 time points (15, 30, 45 and 60
min) after injection. Blood was drawn directly from the heart. The boron
concentrations in blood and samples of skin (pinna), liver and small intestine
were measured using PGNAA. Eight mice received 0.2 ml of the MAC+TAC
liposome solution (316 gg 10B) and were killed at 30 min post-injection for boron
analysis.
The boronated amino acid, p-boronophenylalanine (BPA), was used to
provide a uniform boron distribution in blood and tissues for a positive control
experiment. Previous studies have shown that BPA distributes relatively
uniformly from blood into normal tissues at 2-3 hrs post injection [17]. The BPA
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was solubilized for injection as the fructose complex at a concentration of ~83 mg
BPA/ml [18]. Five mice received a single injection of BPA (0.2 ml; 812 mg 10B)
into the retro-orbital sinus and were killed at 2 hrs post-injection for boron
analysis.
3.2.5 Neutron beam irradiation
Whole-body mouse irradiations were carried out in the epithermal neutron
beam at the MIT reactor (MITR) as previously described [19]. Mice were
irradiated in a Lucite holder designed to immobilize unanesthetized mice by all
four feet such that the abdomens were presented to the 16-cm-diameter
horizontal epithermal beam [19]. Unless specifically noted, all doses quoted in
this paper are physical absorbed doses to which no weighting factors have been
applied. Absorbed doses ranging from 3.2 ± 0.2 to 10.0 + 0.7 Gy were
administered with irradiations lasting from 6 to 20 min. The epithermal neutrons
were thermalized by 1.5 cm of Lucite, consisting of the 0.5 cm thick mouse
holder and an additional 1.0 cm sheet of Lucite placed between the holder and
the beam aperture. The mouse bodies were centered at a depth of 2.5 cm.
Photon and fast neutron absorbed dose rates were measured using paired
ionization chambers with walls of graphite and tissue equivalent A-150 plastic.
The absorbed dose from neutron capture in 10B and nitrogen was determined
using the measured difference in the activation of bare and Cd-covered gold foils
and kerma coefficients of 8.66 x 10-8 and 7.88 x 10-12 Gy cm2, respectively. A
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uniform nitrogen concentration of 3.5% by weight was applied for tissue and
boron concentrations measured in the biodistribution studies were used to
determine the absorbed doses in the blood and vessel wall [20].
3.2.6 Vascular dose calculations
The boron neutron capture reactions in the liposome groups occur, by
design, only within the vessel lumen. This creates a non-uniform dose distribution
in which the dose delivered to the vascular endothelium is less than the boron
dose absorbed in the blood volume within the lumen. Rydin, et al. quantified this
effect of vessel geometry on the dose absorbed in an endothelial cell from boron
neutron capture reactions restricted to the lumen of a blood-filled capillary
relative to the boron dose absorbed in the blood [21]. According to this model,
when 10B is restricted to the lumen, the boron dose absorbed in the capillary wall
is 1/3 of the boron dose absorbed in the blood, given a capillary wall thickness of
0.25 ýtm, which is considered representative for the mice used in this study. The
total physical absorbed dose in the vascular endothelium is the sum of the
external beam dose and the vascular-specific boron dose.
3.2.7 Crypt regeneration assay
The intestinal crypt microcolony assay [3] was used to quantify the effects
of the different absorbed dose distributions delivered to the microvasculature and
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to the intestinal crypt stem cells. This assay has several advantages such as a
steep dose response relationship and independence from the dose to adjacent
normal tissues. Based on its sensitivity, it has been used to quantify the different
biological effects of clinical fast neutron therapy beams differing in radiation
quality by no more than about 10% [22]. In the studies reported here, mice
received whole-body neutron beam irradiation either without administered boron,
30 ± 5 min after a 0.2 ml liposome injection or 2 hrs after injection of BPA. The
mice were killed 84 ± 1 h after irradiation, and a 5 cm section of the jejunum was
removed, cut into 0.5 cm segments and placed into 10% formalin fixative for 24-
48 hrs. After fixation, the intestine sections were embedded vertically in paraffin
to generate cross-sections when cut and then stained with hematoxylin and eosin
(H&E). The numbers of regenerating crypts per circumference were counted
using at least four sections per mouse and 4 mice per dose point. The criteria
used for scoring a regenerating crypt were 10 or more contiguous epithelial cells
and at least one Paneth cell [2, 3]. No correction factor was applied, as the
average crypt size in all irradiated groups was the same. A single, blinded
observer scored all slides.
3.2.8 Survival studies
Mouse survival experiments were carried out at whole-body epithermal
neutron beam absorbed doses of 5.7 ± 0.4, 7.5 ± 0.5, 8.3 ± 0.6, 9.0 ± 0.6 and
10.0 ±+ 0.7 Gy. At the three lowest doses, groups of 8-12 mice received either
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beam-only irradiation or irradiation together with boronated liposomes in the
blood. The MAC liposomes were used for the 5.7 Gy dose level, and the
MAC+TAC liposomes were used for both the 7.5 and 8.3 Gy dose levels. No
boronated liposomes were administered for the 9.0 and 10.0 Gy dose levels.
Mice were weighed daily following irradiation and killed upon entering a moribund
state. Intestine and femur samples were harvested for histology to ascertain the
likely mode of death.
3.3 Results
3.3.1 Biodistribution
The variation in the blood-boron concentration between 15 and 60 min
after injection of the MAC liposome preparation is shown in Fig. 3-1. At 30 min
post-injection, the boron concentration in blood was found to be 45 ± 7 gg 10Bi/g.
The 10B concentrations in liver, skin and small intestine were 18 ± 2 gg 10B/g, 3.7
± 0.2 gg 10B/g and 0.6 ± 1.0 gg 10Bi/g, respectively. The low boron concentrations
observed in the skin and intestine are most likely due to the blood content of the
tissue samples analyzed. Thirty minutes post-injection was chosen as the time of
irradiation based on both the boron biodistribution as well as logistical reasons












0 10 20 30 40 50 60 70
Time (min)
Figure 3-1. 10B concentrations in blood and tissues as a function of time following
injection of 0.2 ml of the MAC liposome preparation into the retro-orbital sinus. Points
represent the mean ± SD; 5 mice per time point.
irradiations. The MAC+TAC liposome solution was used to provide a higher
blood-boron concentration. Eight additional mice received a 0.2 ml injection of
the MAC+TAC liposome preparation and were killed at 30 min post-injection.
The 10B concentrations in blood, liver and small intestine were 118 ± 12 tg 10B/g,
61 ± 3 gg 1oB/g and 0.54 ± 0.49 gg 10B/g, respectively. As expected, the blood-
boron concentration scaled proportionately with the increased boron content in
the MAC+TAC liposome solution. The boron concentration in the small intestine
was below the PGNAA detection limit, as was the case for the MAC liposomes.
A 2-hr post-injection time point was chosen for the BPA biodistribution









The 10B concentrations in blood and small intestine were 13.7 ± 4.6 and 13.0 ±
3.6 ýtg 10Bi/g, respectively (n = 5).
3.3.2 Dosimetry
The total absorbed dose rate in the epithermal neutron beam was 0.57 ±
0.04 Gy min-' at a depth of 2.5 cm and was comprised of 77% low-linear energy
transfer (LET) photons and 23% high-LET radiations, which are principally
protons arising from thermal neutron capture in nitrogen. The relative uncertainty
on the neutron beam doses was 2.2%, which includes only the statistical
uncertainty in the beam monitor counts and variations of approximately 1 mm in
positioning of the irradiation jig along the center of the beam central axis. The
additional absorbed dose rate from the 10B capture reaction was 3.3 ± 0.18 cGy
min-' per gg 10B present.
The total absorbed dose rate in the vascular endothelial cells, with
boronated liposomes in the blood at the time of neutron irradiation, was
estimated as the sum of the whole-body neutron beam absorbed dose rate plus
1/3 of the 10B absorbed dose rate in the blood (Table 3-1). The additional
absorbed dose rate in the microvasculature coming from boron neutron capture
reactions in the blood was 1.1 ± 0.06 cGy min- per gg 10B, which includes the
geometrical factor of 1/3 [21]. The higher 10B concentration in the blood
associated with the MAC+TAC liposomes allowed the dose to the vascular
endothelial cells to be increased, while holding all other parameters constant.
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Thus, the total absorbed dose rate in the microvasculature was 1.08 ± 0.09 Gy
min-' or 1.90 ± 0.16 Gy min 1-' with 45 ± 7 or 118 ± 12 jig 10Bi/g in the blood,
respectively. The stated uncertainties on the microvascular absorbed dose rates
include the uncertainty in the neutron beam dosimetry as well as the uncertainty
in the blood-boron concentration at the time of irradiation.
3.3.3 Intestinal crypt regeneration assay
The numbers of regenerating crypts per intestinal cross section as a
function of the physical absorbed doses from the epithermal neutron
beam are shown in Fig. 3-2 for the four experimental groups (epithermal neutron
beam only, irradiation with either the MAC or the MAC+TAC liposomes in the
blood, or the BPA positive control). The crypt regeneration data points for the two
groups that received liposome injections and beam doses above 6 Gy were
within 1 standard deviation of the exponential fit to the beam-only dose response
data (Fig. 3-2) despite the presence of 45 ± 7 or 118 ± 12 jg 10B/g in the blood
and estimated endothelial cell doses that were 2 or 3 times higher than the
whole-body beam doses (Table 3-1). Regression fits of the beam-only and the
beam plus liposome data in the linear region of the dose response relationship
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Figure 3-2. Number of regenerating crypts per intestinal circumference as a function of
neutron beam dose 84 ± 1 hours after whole-body irradiation in the presence or absence of
boronated liposomes in the blood or with a uniform 10B distribution using BPA. The
triangles and squares represent irradiation conditions where the dose to the
microvasculature was increased, relative to the rest of the mouse, by a factor of 2 or 3,
respectively. Points represent the mean ± SD of at least 16 jejunal cross sections, 4
sections from each of 4 mice.
and 7.1 + 0.6 Gy (beam + (MAC+TAC)) were required to reduce crypt stem cell
survival to the level of 20 regenerating crypts per circumference. The added
absorbed dose selectively delivered to the vascular endothelial cells in the beam
plus liposome groups did not contribute to intestinal crypt stem cell depletion.
Liposome injections with no neutron irradiation had no effect on crypt
regeneration numbers compared to the non-treated controls.
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Table 3-1: Beam doses, total blood doses, and endothelial cell doses used
in the survival experiments.
Beam-only B in blood 1  Total blood Endothelial cellB01 in blood' Total blood 3dose 2 dose(Gy) (pg 1°B/g) dose (Gy) (Gy)(Gy) (y
5.7 ± 0.4 45 ± 7 20.9 ± 1.0 10.8 ± 0.9
7.5 ± 0.5 118 ± 12 60.1 ± 5.7 25.0 ± 2.0
8.3 ± 0.6 118 ± 12 66.5 ± 6.3 27.7 ± 2.2
9.0 ± 0.6 0 9.0 0.6 9.0 + 0.6
10.0 ± 0.7 0 10.0 + 0.7 10.0 + 0.7
1 MAC liposomes or MAC+TAC liposomes were used to produce 45 ± 7 or 118
12 gg 10Bi/g in the blood, respectively.
2 Total blood dose (Gy) = beam dose + 10B dose to the blood
3 Endothelial cell dose (Gy) = beam dose + (1/3)( 10B dose to the blood)
The data shown in Fig. 3-2 are in good agreement with the published data
of Gueulette in the same mouse (BALB/c) using the same irradiation jig and
geometry in the same neutron beam [19]. In that study, the MITR epithermal
neutron beam was shown to have a relative biological effectiveness of 1.5 ± 0.04,
relative to 6 MV photons, for the crypt regeneration endpoint [19]. Thus, the
neutron beam absorbed doses of 3.2-10.0 Gy used here, which are a mix of
high- and low-LET radiations, correspond to photon-equivalent doses of 4.8-15.0
Gy for the crypt survival endpoint. Fig. 2 shows that there were less than 10
regenerating crypts per circumference for an absorbed dose of 8.3 Gy (12.5 Gy
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photon-equivalent), which is consistent with this dose being near the threshold
for a GI death.
The number of regenerating crypts per intestinal cross section following
neutron irradiation in the presence of a uniform 10B concentration in blood and
intestine, as delivered by BPA, is also shown in Fig. 3-2. The intent of this BPA
positive control experiment was to estimate the sensitivity of the crypt
regeneration assay for the detection of potential 10B diffusion out of the vessels.
The presence of -13 pg 10B/g in both blood and intestine increased the physical
absorbed dose rate by 75%, or by an additional 0.43 Gy min'. The BPA positive
control dose response curve is shifted significantly to the left when plotted versus
the beam dose (Fig. 3-2). Based on these data, we estimate that the crypt
regeneration assay could detect the effect of the added 10B dose from as little as
2 jLg 10B/g outside the vessels, which represents less than 2% "leakage" of the
MAC+TAC blood-boron concentration.
Even with all 10B restricted to the vessel lumen, the ranges of the alpha
and lithium particles (9jm and 5pm) are such that some dose will be absorbed
outside of the vessel wall. Monte Carlo simulations show that the 10B dose
gradient outside the vessel drops off steeply. For example, for the 8.3 Gy beam
dose with the MAC+TAC liposomes (118 pg 10B/g in the blood: Table 3-1) the
absorbed 10B dose to the blood inside the vessel lumen is 58.2 Gy. Outside the
vessel, at distances of 2, 5 and 7 pjm from the vessel wall, the 10B dose
component is 3.0, 0.2 and 0.005 Gy, respectively. However, the crypt
microcolony assay results (Fig. 3-2) indicate that this potential penetration of the
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Figure 3-3. A. Mouse survival after whole-body neutron beam-only irradiations. B. Mouse
survival after whole-body neutron irradiation with boronated liposomes present in the
blood. The microvascular absorbed doses were 10.8 ± 0.9 (MAC), 25.0 + 2.0 (MAC+TAC)
and 27.7 ± 2.2 Gy (MAC+TAC), respectively.
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3.3.4 Mouse survival
Figure 3-3A shows the survival of the beam-only groups as a function of
time after whole-body neutron beam irradiation. All mice (n=12) given 5.7 Gy and
8 of 10 mice given 7.5 Gy lived beyond 30 days, indicating that these beam
doses were below the LDs50 for death from a bone marrow syndrome. At neutron
beam doses of 8.3, 9.0 and 10.0 Gy, all mice (n=28 total) died within 4-9 days
(Fig. 3-3A). Figure 4 shows H&E-stained histological sections of small intestine
(jejunum) and bone marrow from mice in the 8.3 and 9.0 Gy beam-only groups
that were killed 9 and 5 days after irradiation, respectively. The intestinal mucosa
was well on the way to recovery in the mouse that received the 8.3 Gy beam-only
dose, whereas the intestinal epithelium was severely denuded in the mouse that
received the 9.0 Gy beam-only dose, which is indicative of death from the GI
syndrome. The bone marrow was severely depleted and showed extensive
necrosis of the matrix and widespread hemorrhaging in both mice. Thus, the
histopathology from the neutron beam-only irradiation groups indicates that the
transition from a bone marrow death to a GI syndrome-induced death occurs at a
whole-body absorbed dose between 8.3 and 9.0 Gy.
Figure 3-3 B shows the survival of the beam plus liposome groups as a
function of time after whole-body neutron beam irradiation with boronated
liposomes in the blood. The estimated total absorbed doses in the vascular
endothelial cells were 2 or 3 times higher than the whole-body absorbed doses
received by the crypt stem cells (Table 3-1). In the 5.7 Gy + MAC group, 11 of 12
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mice lived beyond 30 days, whereas all mice (n=10) in the 7.5 Gy + (MAC+TAC)
group and all mice (n=8) in the 8.3 Gy + (MAC+TAC) group died within 6-7 days.
Figure 3-4 shows H&E-stained small intestine (jejunum) and bone marrow
sections from a mouse in the 8.3 Gy + (MAC+TAC) group killed 7 days after
irradiation. The intestinal mucosa recovered, whereas the bone marrow was
severely
8.3 Gy beam-only;
killed on day 9.
8.3 Gy beam +
(MAC+TAC);




killed on day 5.
Figure 3-4. Histopathology in small intestine and bone marrow after whole-body neutron
beam-only absorbed doses of 8.3 ± 0.6 or 9.0 ± 0.6 Gy. Also shown are tissues from a
mouse in the 8.3 Gy + (MAC+TAC) liposomes group where the calculated absorbed dose
to the endothelial cells was 27.7 ± 2.2 Gy.
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depleted, indicating that this mouse died from the bone marrow syndrome
despite a physical absorbed dose in the microvasculature that exceeded 27 Gy.
The 7.5 Gy beam-only and 7.5 Gy + (MAC+TAC) groups show
considerably different survival times (Fig. 3-3), yet the mode of death was the
same in both groups, namely, bone marrow depletion. The very high (> 50 Gy)
absorbed dose in the blood (see Table 3-1) in the presence of the MAC+TAC
liposomes contributed enough dose to the bone marrow to cause a rapid death
from the bone marrow syndrome. The exact mechanism of liposome-mediated
delivery of boron into the bone marrow is under investigation.
3.4 Discussion
The cellular and sub-cellular events that eventually lead to the breakdown
of tissue structure and function are initiated at the time of irradiation. Our ability to
preferentially increase the absorbed dose to the vascular endothelial cells allows
direct testing of the role played by microvascular damage in the subsequent
development of normal tissue damage. We have established that whole-body
neutron beam-only doses of approximately 9.0 Gy represent the threshold for
death from the GI syndrome. Our approach was to use neutron beam doses
below the 9.0 Gy threshold for the GI syndrome in combination with boronated
liposomes in the blood. The additional short-ranged boron neutron capture dose
in the blood selectively increased the total absorbed dose in the microvasculature
to values as high as 27.7 Gy, while the dose to the crypts remained below 9.0 Gy.
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Despite these extremely high doses to the microvasculature, the crypt
microcolony assay and histopathological confirmation of the mode of death
indicated that all observed radiation effects in the small intestine could be
attributed to the whole-body neutron beam dose: the added dose to the
microvasculature was inconsequential. This leads us to the conclusion that
damage to the intestinal microvasculature is not causative in the loss of stem cell
function and the eventual depopulation of the intestinal lining that characterizes
the gastrointestinal syndrome.
The role of microvascular versus parenchymal cell damage has long been
a matter of considerable debate for late effects [23-25]. In recent years, it has
become clear that the overall tissue response to radiation damage includes a
complex interaction between the different cell types present that begins
immediately after the radiation insult and persists throughout the clinically silent
period until the expression of the late effect months or even years later.
Radiation has been shown to result in the activation of a number of early-
response cytokines which act through diverse signaling pathways [26]. This
continuous cascade of cytokines has been proposed to induce a chronic
inflammatory phase, which is in turn followed by late stromal alterations such as
fibrosis [27]. Radiation injury has also been likened to a "complex wound" where
persistent damage to the vascular endothelium results in eventual dysregulation
of the coagulation system, which in turn causes a chronic inflammatory response
leading to fibrotic changes [28]. Despite the increased understanding of the
molecular responses in tissue to radiation exposure, questions still remain as to
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which cell population(s) are the critical targets that initiate these signaling
pathways, due in large part to the lack of experimental techniques for selectively
irradiating potential target populations to test these hypotheses.
The present study is similar in concept to previous work by us that
addressed the role of vascular damage in the development of both subacute and
late effects in the central nervous system [9, 10]. In those studies, the blood brain
(or spinal cord) barrier was used to keep a low molecular weight boron
compound (Na2B12H1 ,SH, or BSH) within the lumen of the blood vessels during
neutron irradiation. In the spinal cord study [10], an in vivo/in vitro assay for O-2A
glial progenitor cells showed that, following uniform irradiation with the neutron
beam alone, the glial progenitor population was severely depleted at 1 week and
remained so until the development of white matter necrosis and limb paralysis at
6 months post-irradiation. In contrast, the glial progenitor population remained at
high levels at all times following the irradiation with the neutron beam plus BSH in
the blood. Both irradiation conditions were iso-effective for white matter necrosis
[29]. The conclusion from that study was that damage to the vascular
endothelium was the primary event leading to white matter necrosis [10]. In the
rat brain study [9], at 30 days post-irradiation, the loss of neural precursor cells
and their progeny was shown to correlate with the absorbed dose in the brain
parenchyma (the beam dose) and was not affected by the selective irradiation of
the microvasculature [9]. The results in the rat brain parallel what we report here
for the acute loss of mouse intestinal crypt stem cells: the effect is direct and not
mediated by the vascular dose.
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The mixed high- and low-LET nature of the physical absorbed doses in the
microvasculature reported here complicates a direct comparison to the low-LET
doses used by Paris et al., [5]. However, a biological weighting factor has been
measured for BSH in the rat spinal cord using the myeloparesis endpoint [29],
where white matter necrosis has been shown to be directly related to vascular
damage [11, 12]. BSH in the CNS produces the same 10B distribution pattemrn as
the liposomes in the intestine in the current study: the 10B is restricted to the
vessel lumen. The weighting factor derived in the rat spinal cord for BSH is 0.46
and converts the 10B physical dose absorbed in the blood into a photon-
equivalent dose to the vasculature [29]. Application of the BSH weighting factor
to the liposome 10B blood doses (Table 3-1) generates estimated photon
equivalent doses to the intestinal vasculature of 7.0, 24.2 and 26.8 Gy. In
addition, the vasculature also received the non-specific beam dose. Clearly, the
upper range of the doses delivered to the vasculature in the beam plus liposome
irradiations reported here are significantly higher than the 8-15 Gy photon dose
range used in the Paris et al. study [5].
The proof-of- principle results described here suggest that our technique
for selective vascular irradiation could be useful in other non-CNS tissues such
as the lung, where the role of vascular endothelial cell apoptosis as the initiating
event in the development of lethal radiation pneumonitis in the mouse is a matter
of debate [30, 31]. This approach could also play an important role in studies of
the molecular mechanisms leading to late fibrosis in tissues such as the lung, the
gastrointestinal tract or the kidney. Understanding the mechanisms which
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regulate both early and late normal tissue radiation responses may have
important implications and applications in the development of radiation protectors
or treatments for radiation exposures.
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Chapter 4: No Significant Endothelial Apoptosis in the
Radiation Induced Gastrointestinal Syndrome*
4.1 Introduction
Microvascular versus parenchymal cell damage as the initiating event in
radiation-induced normal tissue side effects has long been a matter of
considerable debate. For late effects, the demonstration of a continuous cytokine
signaling cascade throughout the latent period [1], together with reports that late
effects could be modified pharmacologically [2], contributed to the current
understanding that late-appearing changes are not necessarily the inevitable
consequence of damage to a single target cell population, but, rather, the overall
tissue response to the initial radiation damage [3]. Acute damage in rapidly-
proliferating normal tissues has historically been assumed to be a direct result of
the radiation inactivation of the stem cell populations supporting these tissues.
The radiation-induced gastrointestinal (GI) syndrome is characterized by massive
depletion of the intestinal epithelial lining leading to death in -5-10 days, which
reflects the functional lifetime of the differentiated epithelial cells. Recently, it was
proposed that an early (4 hrs post-irradiation) wave of apoptosis in murine
intestinal microvascular endothelial cells was the initiating event leading to the GI
syndrome [4], a hypothesis which remains controversial [5-7].
* Schuller, B.W., A.B. Rogers, K.S. Cormier, K.J. Riley, P.J. Binns, R. Julius, M.F. Hawthorne,
and J.A. Coderre, No significant endothelial apoptosis in the radiation-induced gastrointestinal
syndrome. Int J Radiat Oncol Biol Phys, 2007. 68(1): p. 205-10.
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To directly test the role of vascular damage in the response of tissues to
irradiation, we introduced a method for selective irradiation of the vascular
endothelium that entails whole-body irradiation with low-energy neutrons in the
presence of 10B-labeled compounds that remain in the blood. The short-ranges
(5-9 pm) of the alpha and lithium particles released following neutron-capture by
10B in the blood result in a >3-fold higher radiation dose absorbed in the
microvasculature. Using the blood brain barrier to restrict a low-molecular weight
boron compound to the blood, we showed that vascular damage was the critical
factor in the subsequent development of late damage (white matter necrosis) in
the rat spinal cord [8]. However, it was the direct brain dose, and not the vascular
dose, that correlated with a subacute (30 days) effect (loss of neural precursor
cells) in the rat brain [9].
To address the role of vascular damage in tissues not protected by the
blood brain barrier, we used the selective vascular irradiation approach with
boron-loaded liposomes [10]. In the mouse small intestine, we showed that the
significantly higher doses selectively delivered to the vascular endothelium (a)
did not cause any additional loss of murine intestinal crypts, and (b) did not
increase the incidence of death from the GI syndrome, beyond that produced by
the neutron beam alone [10]. Here, we use the selective vascular irradiation
methodology to address the hypothesis that early endothelial cell apoptosis is the
cause of the GI syndrome.
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4.2 Materials and Methods
4.2.1 Boronated liposomes
The 10B-containing liposome formulations used for the mouse intestine
studies were prepared as previously described [10, 11]. The liposome
formulations had a mean vesicle diameter between 70 and 90 nm and contained
24 mg total lipid/mI. Boron concentrations of ~1580 jig 10B/ml were determined
by prompt gamma neutron activation analysis for the liposome injection solution.
4.2.2 Irradiation conditions and dosimetry
All animal protocols were approved by the MIT Committee on Animal Care
and were conducted according to the principles outlined in the Guide for the Care
and Use of Laboratory Animals prepared by the Institute of Laboratory Animal
Resources, National Research Council. Unanesthetized mice received whole-
body irradiation with 250 kVp x-rays, 137Cs gamma rays or epithermal neutrons at
dose rates of 2.5 Gy/min, 0.69 Gy/min and 0.57 Gy/min respectively that were
measured using separate graphite- and A-150 plastic-walled ionization chambers.
Absorbed dose in tissue using the epithermal neutron beam was comprised of
77% low-linear energy transfer (LET) photons and 23% high-LET reaction
products, primarily protons produced in tissue by thermal neutron capture in
nitrogen. In all irradiations, the dose to the blood vessels was assumed to be
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equivalent to the whole-body dose and hence the dose to the crypt cells except
for those performed in the neutron beam following the injection of liposomes
containing boron. Under these irradiation conditions, the blood vessels received
an additional dose resulting from secondary charged particles (alpha particle and
lithium ion) produced in the blood following the capture of thermal neutrons by
boron. The dose to the capillary wall from the presence of boron in the blood was
determined from thermal neutron flux measurements performed in a nylon mouse
phantom with bare and cadmium covered Au activation foils. The thermal neutron
flux was multiplied by the weight fraction of boron in the blood of the mice,
measured in previous biodistribution studies, a kerma coefficient of 8.66 x 10-8
Gy cm2 and a geometry factor of 1/3. The geometry factor accounts for the non-
uniform distribution of traversals in the capillary wall from the secondary charged
particles that only emanate from the vessel lumen. The geometry factor varies
depending upon both the diameter and wall thickness of the capillary [12, 13].
Based upon previous studies for a 8 pm-diameter capillary with a wall thickness
of 0.25 pm, a geometrical reduction factor of 1/3 was considered appropriate [12]
and the additional absorbed dose rate in the blood vessel wall from the 10B
capture reaction was 1.1 ± 0.06 cGy min 1' per [tg "10B/g present in the blood [10].
Irradiations began 30 ± 5 min after injection of the boronated-liposome solution
(0.2 ml, retro-orbital sinus) when the 10B blood concentration, measured in
previous biodistribution studies [10], was 118 ± 12 ýtg 10B/g. Thus, for the
selective vascular irradiation group, the whole-body dose rate from the neutron
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beam was 0.57 Gy/min while the concurrent dose rate to the endothelial cells in
all vessels was 1.9 Gy/min, a factor of 3.3 higher.
4.2.3 Histology and TUNEL staining
Intestinal (jejunum) sections were stained by the terminal deoxynucleotidyl
transferase biotin-dUTP nick end labeling (TUNEL) method at an outside
laboratory (Mass Histology, Worcester, MA) using a commercial kit (Dead End
Colorimetric TUNEL System; Promega, Madison, WI). Positive tissue controls
(irradiated thymus) and negative antibody controls (irrelevant mouse IgG
replacing the primary antibody) were included in all TUNEL staining experiments.
Jejunal sections were scored for all TUNEL-positive nuclei in the lamina propria
of the villi using 50 villi per mouse and three mice per data point, with the
following exceptions. The 250 kVp x-ray, BALB/c points contain only 1 mouse per
point; the C57B1/6 12 and 16 Gy 137Cs contain 6 mice per point and represent
two independent experiments.
4.2.4 Fluorescence immunohistochemistry
Unstained formalin-fixed paraffin-embedded jejunal sections were
deparaffinized and subjected to heat-induced epitope retrieval in a commercial
rice steamer for 20 min in pH 6 citrate buffer (DAKO Cytomation, Carpinteria,
CA) followed by benchtop cooling. All remaining steps were performed as
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described elsewhere [14] on an automated i6000 immunostainer (Biogenex, San
Ramon, CA). Primary antibodies were sequentially labeled, with a biotin blocking
step between markers. Apoptotic cells were labeled with rabbit monoclonal anti-
caspase-3 antibody specific for the cleaved (activated) fragment (Cell Signaling
Technologies, Beverly, MA), followed by goat anti-rabbit secondary antibody
conjugated with Alexa Fluor 488 (Molecular Probes / Invitrogen, Eugene, OR).
Endothelium was labeled with Meca-32 (rat anti-mouse anti-plasmalemma
vesicle-associated protein; Developmental Studies Hybridoma Bank, University
of Iowa, Iowa City, IA) followed by biotinylated secondary antibody, and then
visualized by incubation with streptavidin-Cy3 (Amersham). Rat anti-mouse
common leukocyte antigen (CD45, Ly5; BD Biosciences, San Jose, CA) was
labeled as described for Meca-32. Nuclei were counterstained blue by mounting
slides with antifade Vectashield plus DAPI (Vector Laboratories, Burlingame, CA).
Positive tissue controls (a chemotherapeutic-treated mouse xenograft) and
negative antibody controls (irrelevant mouse IgG replacing the primary activated
caspase-3 antibody) were included in all immunofluorescence staining
experiments. Fluorescent images were captured with a Zeiss Axioskop 2 system
and individual panels merged in Adobe Photoshop. In order to overcome the
problem of tissue autofluorescence at the fluorescein excitation maximum of
~490A, we evaluated photomicrographs taken through a long-pass emission filter,
which permitted the passage of all light >515A following excitation at 450-490 A.
By this method, autofluorescence appeared as yellow due to the combined
emission of red and green wavelengths, whereas Alexa Fluor 488-labeled cells
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emitted only green light with an excitation maximum of 519 A. In agreement with
prior experience and published results, autofluorescence was particularly intense
in formalin-fixed red blood cells (RBCs) within blood vessels. We eliminated
bright autofluorescence through color subtraction. The more diffuse pale tissue
autofluorescence was eliminated by thresholding techniques.
4.3 Results
The number of TUNEL-positive nuclei per villus showed no dose response
between 1 and 33 Gy for either BALB/c or C57BI/6 mice using four different
irradiation modalities as shown in Fig. 4-1 a. The doses expressed on the x-axis
of Fig. 4-1 a are to the blood vessels which, except for the selective vascular
irradiation group (neutrons + liposomes), are equivalent to the whole-body doses.
All irradiation groups represented in Fig. 4-la include data above the dose
thresholds for death from the GI syndrome (as judged by histology on bone
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Figure 4-1. (a) TUNEL-positive nuclei in the lamina propria of mouse jejunal villi, at 4 h
post-irradiation, as a function of blood vessel dose. Points represent the mean ± SEM, 50
villi per mouse, all scored by a single blinded observer. (b) TUNEL staining demonstrates
few apoptotic cells in jejunal villi (arrows) when compared with intestinal crypt (inset);
both at 4 h after 12 Gy 250 kVp x-rays. (c) Fluorescence imaging 4 h after 12 Gy of 250 kVp
x-rays. The vascular endothelium (Meca-32, Cy3, red, arrowheads) and the apoptosis
(caspase-3, fluorescine, green, arrow) labels do not co-localize. Nuclei were counter-
stained blue with DAPI. (d) A lone caspase-3-positive cell (fluorescine, green, arrow)
expresses on its surface the common leukocyte antigen CD45 (Cy3, red). Scale bars: (b)




for 250 kVp x-rays; and 14-15 Gy for 13 70S gamma rays. Scoring of TUNEL-
positive cells per villus indicated 0.12 ± 0.04 apoptotic cells/villus for the
unirradiated controls. When the data for all irradiation groups shown in Fig. 4-la
were combined (59 mice, 50 villi/mouse), the mean number of apoptotic cells
scored per villus was 1.62 ± 0.03 (SEM) (range 0-12, median 1, mode 0).
Apoptotic epithelial cells were, however, observed in intestinal crypts (Fig. 4-1 b,
inset) at all doses. These cells are radiation-sensitive and are known to exhibit an
apoptotic dose-response that saturates at doses above ~ 1 Gy [7]. For the same
irradiation groups shown in Fig. 4-la, the number of apoptotic cells per crypt was
3.3 ± 0.1 (mean ± SEM, one mouse scored/point, 10 crypts/mouse). The number
of apoptotic cells per crypt was significantly greater than the number per villus
(P<0.0001). Scoring of TUNEL-positive cells per villus at 8 hrs post irradiation (12,
16 or 19 Gy, 250 kVp x-rays, C57B1/6 mice, n=1/dose level) resulted in the same
low level of apoptosis as shown in Fig. 4-la for 4 hrs post irradiation.
Representative thymus samples from all irradiated groups (250 kVp x-rays, 1370S
gamma rays, neutrons alone, neutrons + liposomes) all showed extensive
TUNEL staining at 4 hrs post-irradiation (data not shown).
The TUNEL method can be prone to false-positive labeling of cells in the
intestinal villi related to tissue fixation or antigen retrieval procedures [15, 16]. To
independently confirm and extend the TUNEL results, we used fluorescence
immunohistochemistry for detection of activated caspase-3, which has been
shown to correlate well with apoptosis identified using morphological criteria [16].
More cleaved caspase-3-positive cells were located in crypt epithelium than in
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Figure 4-2. Double-label fluorescence immunohistochemistry in formalin-fixed, paraffin-
embedded jejunum from a mouse irradiated with 12 Gy of 250 kVp x-rays, demonstrating
elimination of confounding autofluorescence. (a) When excited at 450 - 490 A and viewed
through a narrow-pass emission filter (515-565 A; green light only), there appear to be
many cleaved-caspase 3-positive (fluorescein-labeled, green) cells in the villus. (b)
Vascular endothelial cells are demonstrated by Meca-32 labeling (Cy3, red, excitation 546
A, emission >590 A). (c) Merged image appears to show both Meca-32-positive
(arrowheads) and Meca-32-negative (arrow) cleaved caspase-3-positive cells. (d) When
excited at 450 - 490 A and viewed through a long-pass emission filter (allowing passage of
all wavelengths > 515 A) most fluorescent figures are shown to be the result of tissue
autofluorescence (yellow, arrowheads) with only a single central figure retaining green
fluorescent properties (arrow). (e) Meca-32 overlay demonstrates that endothelial cell-
associated figures are autofluorescent erythrocytes. (f) Removing autofluorescence by
color subtraction, only the central non-endothelial cell is confirmed to be a fluorescein-
labeled cleaved caspase-3-positive cell (arrow). DAPI nuclear counterstain (blue) included
in all panels (excitation 365 A, emission >420 A). Scale bar: 50 pm for all panels.
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villi, in agreement with the TUNEL data shown in Fig. 4-1. We observed no co-
localization of endothelial and apoptotic markers within intestinal villi (Fig. 4-1c).
Most caspase-3-positive apoptotic cells within villi were localized to the central
lamina propria, and not the subepithelial capillary bed, and were identified as
CD45-positive leukocytes (Fig. 4-1d). Figure 4-2 illustrates the importance of
background correction for tissue autofluorescence that we applied in this work.
The multi-wavelength emission (yellow) of autofluorescent compounds,
particularly in erythrocytes, is readily apparent when viewed through a long-pass
filter (Fig. 4-2d), but produces false-positive labeling when viewed with a narrow-
pass filter at the fluophore maximum emission (green) wavelength (Figs. 4-2a,c).
4.4 Discussion
Rapidly renewing normal tissues such as the bone marrow, the intestinal
epithelium, and the oral mucosa are arranged into functional units that include a
stem cell population and differentiated functional cells with a finite lifetime. The
appearance of radiation-induced tissue damage is directly related to the cell
turnover kinetics, and the finite lifetimes of the differentiated functional cells.
Both the stem cells and the functional cells must be supplied by a network of
blood vessels, also comprised of cells with a finite lifetime. Traditionally, it has
been thought that acute effects result from the direct killing of the rapidly growing
stem cell population and a loss of function because the differentiated functional
cells are no longer being replaced. In the intestine, this assumption has been
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supported by substantial experimental data showing a linear dose response
relationship for crypt stem cell survival, (usually measured as regenerating crypts
at 3-4 days post irradiation) [7, 17, 18].
Recent reports have suggested that early (4 hrs post-irradiation)
endothelial cell apoptosis in the lamina propria is the primary lesion initiating the
GI syndrome following whole-body photon irradiation [4,19]. A massive increase
in the extent of intestinal endothelial cell apoptosis was described when the
radiation dose was increased above the threshold for death from the GI
syndrome [4]. Deletion of acid sphingomyelinase changed the mode of death
from the GI syndrome to the bone marrow syndrome; in effect, producing about 3
Gy of radioprotection [4]. The vascular endothelium in the acid
sphingomyelinase-deficient mice exhibited a substantially reduced apoptotic
response to radiation compared to wild-type mice [4]. Administration of basic
fibroblast growth factor [4] or an angiopoietin analog [19] was shown to reduce
the extent of apoptosis in intestinal endothelial cells and to provide some degree
of radioprotection (increase in mean survival time). Apoptotic intestinal
leukocytes, together with a subpopulation of apoptotic endothelial cells, have
been described in irradiated mice with standard murine microflora [20]. Although
the relative frequency of each population was not reported, the total number of
apoptotic cells per villus was comparatively low in wild-type mice (approximately
3 per villus) after 16 Gy whole-body irradiation, which is consistent with the total
number of apoptotic cells per villus that we report here (1.62 + 0.03, Fig. 4-1a).
Whereas it is possible that we overlooked a rare apoptotic endothelial cell, we
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cannot envision a scenario by which such a small number could account for the
massive tissue loss associated with the radiation-induced GI syndrome. Potten
has also reported that although abundant apoptosis could be observed at early (4
hrs) and late (10 hrs) times in the crypt epithelial cells, little or no apoptosis was
observed in the stroma or the endothelial cells [7].
Much of the disagreement over the sequence of events leading ultimately
to the massive epithelial cell depletion that characterizes the GI syndrome, stems
from the lack of experimental techniques to directly test hypotheses. We have
developed a methodology that allows us to selectively increase the dose to
vascular endothelial cells relative to the dose absorbed in the rest of the body by
a factor of 3. This enables, for the first time, a direct investigation of the role of
vascular damage in the response of normal tissues to irradiation. The selective
vascular irradiation methodology depends on boron being present in the blood
during the neutron irradiation and that it is retained within the lumen of the
vessels. In our previous study of the mouse small intestine [10] we
experimentally validated the method by performing biodistributions for boron in
blood and other tissues at different time points following injection as well as
quantifying the increased potency in crypt cell depletion with boron present
outside the vessels during neutron irradiations. This was to simulate what might
occur should boron leak from the vessel lumen when using the boronated
liposomes. Briefly, a positive control group was included with 13 pg 1'0B/g both in
the blood and in the normal tissues, including the intestine. Neutron irradiation
produced a significant shift in the crypt regeneration dose response curve which
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indicates that the crypt regeneration assay is sensitive enough to allow us to
discern the additional dose resulting from as little as 2 pg 10Bi/g outside the
vessels. In that study the crypt regeneration dose response data were the same
for neutrons alone and neutrons in the presence of boronated liposomes
(providing a concentration of 118 pg 10Bi/g confined to the blood) from which it
was concluded that there was no significant leakage of liposomal boron out of the
blood vessels at the time of irradiation [10].
Data from the selective vascular irradiation experiments are inconsistent
with the hypothesis that endothelial cell apoptosis is the cause of the GI
syndrome. In our previous work, we examined the survival of crypt stem cells at
3.5 days post-irradiation and compared whole-body neutron irradiations with and
without boronated liposomes to selectively increase the vessel dose. We showed
that the greatly increased doses absorbed in the vasculature had no effect on
crypt stem cell depletion at 3.5 days post-irradiation [10]. Here, we have
examined the incidence of apoptosis in the mouse jejunum at 4 hours post-
irradiation. For the same range of neutron doses and selective vascular
irradiation conditions, we have demonstrated that the majority of apoptotic cells
in irradiated mouse intestine are crypt epithelium, and that the few apoptotic cells
present in villi are predominantly tissue-resident leukocytes. We have included
whole-body photon irradiation groups in the present study. For both 250 kVp x-
rays and 137Cs gamma rays, the data are in agreement with our neutron +
liposome data: no dose response is evident in the number of apoptotic cells per
villus for dose ranges that span the threshold for death from the GI syndrome.
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Most significantly, we do not observe the high levels of apoptotic endothelial cells
in the lamina propria of whole-body irradiated mice using the same experimental
conditions reported by others [4, 19]. It was at 15 Gy (137Cs) in C57BI/6 mice that
Paris et al. described a sharp increase in the number of apoptotic cells (-45% of
crypt/villus units showing > 10, and ~25% showing > 20 apoptotic cells) which
was attributed directly to apoptosis in vascular endothelial cells [4]. In summary,
the selective vascular irradiation methodology we have described has provided
an approach to directly address a long-standing and controversial issue in
radiation biology. We conclude that early endothelial apoptosis is not the cause
of the GI syndrome. The selective vascular irradiation methodology appears
ideally suited for elucidating the role of vascular damage in the development of
late effects in normal tissues or in the response of tumors to radiation. Such
information could guide the development of protective or therapeutic strategies.
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Chapter 4 Appendix: Apoptosis in Cultured Human
Microvascular Endothelial Cells (HMEC)
During the course of the apoptosis studies described in this chapter, the
question arose asking whether endothelial cells exposed to high-LET radiation
(the type used in the selective vascular irradiations) will actually undergo
apoptosis or proceed down another pathway such as necrosis. To ascertain
whether vascular endothelial cells will undergo apoptosis in response to high-
LET radiation, human microvascular endothelial cells (HMEC) were irradiated in
vitro using a custom apparatus designed in the Ph.D. thesis work of Rong Wang
(Department of Nuclear Science and Engineering, 2005) [1]. This apparatus
allows the direct irradiation of cultured cells with a-particles (high-LET) using
241Am foils and subsequent in situ staining for DNA. Abundant apoptosis was
found in cultured HMEC following either x-ray (low-LET) or a-particle irradiation
(high-LET).
4A.1 Materials and Methods
To determine the response of microvascular endothelial cells to both high-
and low-LET radiation, HMEC were cultured and exposed to either a-particles
derived from an 241Am source or 250 kVp x-rays. HMEC immortalized with SV40
were obtained from Dr. T. J. Lawley, Biologic Products Branch, Centers for
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Disease Control, Atlanta, GA and grown as a monolayer on a 1.4 pm thick mylar
membrane, which was part of a custom designed cell irradiation apparatus [1].
The monolayer was exposed to either a-particles (mean a-particle energy of 3.14
MeV, LET = 128 keV/pm) at a dose rate of 9.3 Gy min-' or 250 kVp x-rays at a
dose rate of 1.0 Gy min 1 . Absorbed doses of 1.0, 5.0 and 10.0 Gy were
delivered. After irradiation, the HMEC were incubated at 37 °C for 4 hours, fixed
to the mylar membrane with an ice-cold 3:1 methanol-to-acetic acid solution, and
stained with 4,6,diamidino-2-phenylidole (DAPI) (10 pg ml1). The mylar
membrane was then transferred to a glass slide (sandwiching the mylar
membrane between a glass slide and cover-slip and cutting along the edge of the
slide with a scalpel) for analysis by fluorescent microscopy. Apoptotic nuclei were
scored based on the morphologic nuclear changes (condensed and fragmented),
which are characteristic of apoptosis. All slides were scored by a single blinded
observer.
4A.2 Results
The average percentage of apoptotic nuclei as a function of physical dose
is shown in Figure 4A-1. The bars represent the mean of 3 different experiments
(1000 total cells counted per experiment = 3000 total cells) ± 1 standard
deviation. The incidence of apoptotic HMEC increases as a function of physical
dose for both the low-LET x-rays and high-LET a-particles. Alpha-particles are
more effective than x-rays at inducing apoptosis in that there is an apparent
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relative biological effectiveness (RBE) of ~1.4.This experiment shows that high-
LET radiation is able to induce an apoptotic response in microvascular
endothelial cells. Furthermore, the incidence of apoptosis has been shown to
occur after high-LET irradiation [2] and increase with increasing LET in Chinese
hamster V79 cells [3]. Bovine derived microvascular endothelial cells have also
been shown to undergo apoptosis in vitro using low-LET radiation [4]. Given that
a mixture of both high- and low-LET radiation is delivered to the endothelial cells
during our selective vascular irradiation technique (high vascular doses reaching
~27 Gy) [5], we were confident, at least from an in vitro perspective, that













Figure 4A-3. Apoptotic HMEC nuclei (%) as a function of physical dose following a-particle
or x-ray irradiation. Apoptosis in these cells increases as a function of dose for both a-
particles (high-LET) and x-rays (low-LET).
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However, despite the clear in vitro dose response for endothelial
apoptosis presented here, we have shown that endothelial cells will not readily
undergo radiation-induced apoptosis in vivo. This is because a situation is
created in vitro, where cells are placed in an artificial context far removed from
the tissue environment. In an in vivo environment, there must be many other
cellular processes involved to prevent significant levels of endothelial apoptosis.
144
References
1. Wang, R. and J.A. Coderre, A bystander effect in alpha-particle
irradiations of human prostate tumor cells. Radiat Res, 2005. 164(6): p.
711-22.
2. Hendry, J.H., C.S. Potten, and A. Merritt, Apoptosis induced by high- and
low-LET radiations. Radiat Environ Biophys, 1995. 34(1): p. 59-62.
3. Aoki, M., Y. Furusawa, and T. Yamada, LET dependency of heavy-ion
induced apoptosis in V79 cells. J Radiat Res (Tokyo), 2000. 41(2): p. 163-
75.
4. Langley, R.E., E.A. Bump, S.G. Quartuccio, D. Medeiros, and S.J.
Braunhut, Radiation-induced apoptosis in microvascular endothelial cells.
Br J Cancer, 1997. 75(5): p. 666-72.
5. Schuller, B.W., P.J. Binns, K.J. Riley, L. Ma, M.F. Hawthorne, and J.A.
Coderre, Selective irradiation of the vascular endothelium has no effect on
the survival of murine intestinal crypt stem cells. Proc Natl Acad Sci U S A,
2006. 103(10): p. 3787-92.
145
146
Chapter 5: Preliminary Study on Early Inflammatory
Gene Expression Changes Following Selective Vascular
Irradiation
5.1 Introduction
Nearly 50% of cancer patients receive some form of radiation therapy
during the lifetime of their disease. Radiation therapy is an attractive option for
patients and clinicians, because it is a non-invasive treatment modality that will
preserve the tissue architecture while affording some curative or palliative effect,
i.e. tumor shrinkage, pain relief, etc. [1]. However, radiation therapy does come
with risk to the patient, as every cancer patient undergoing radiation therapy will
experience some adverse side effects (early or late) from the treatment. The
number of cancer survivors in the United States is increasing at a rapid rate. For
example, the number of cancer survivors has more than tripled from 1971 to
2001, and this statistic has been met with an increasing concern about the quality
of life for patients post-treatment [1]. Early and late radiation side-effects are the
dose limiting factors during the course of radiation therapy treatment. The
mechanisms underlying early radiation effects are relatively well understood in
that they most often arise in stem-cell-based, rapidly renewing tissues, where
radiation depletes the regenerative stem cell populations causing the ultimate
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loss of tissue structure and function. In contrast, very little is known about the
underlying mechanisms involved in the onset of late radiation effects.
The target-cell hypothesis for radiation damage in normal tissue was the
established model to explain radiation damage for many years, and it more or
less remains as the model used to explain early radiation effects today. However,
recent investigations into the complex biochemical changes that take place in
cells and tissues following irradiation suggest that late radiation effects are a
result of the early activation of inflammatory cytokine cascades that ultimately
lead to tissue changes months to even years after radiation exposure [1-10].
Inflammation is a normal component of wound healing where blood-lymphocytes
and tissue resident macrophages are recruited to the site of injury through
cytokine signaling to help ward off invading microbiota. Activated fibroblasts then
deposit collagen to rebuild the tissue structure as angiogenesis takes place. Anti-
fibrotic cytokines are then up-regulated to enlist the final tissue remodeling phase.
In normal wound healing, activated fibroblasts disappear through active
regulatory control and apoptosis, whereby the inflammation process eventually
dissipates. In some cases a chronic inflammatory state is established where
activated fibroblasts persist for long periods of time. This resembles a 'wound
that does not heal' [11] but continues to release repair signals. The source of this
chronic signaling cascade remains unknown.
The initial stages of radiation-induced fibrosis are indistinguishable from
normal wound healing processes, where there is an almost immediate up-
regulation of pro-inflammatory cytokines such as tumor necrosis factor-a (TNF-a)
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[12] and interleukins 1 and 6 (ILl and IL6). However, abnormal production of
transforming growth factor-#fl (TGF-,8), TNF-a and ILl has been observed in
irradiated tissues, including the small intestine [13], which may establish the
active feedback loop necessary to establish a state of chronic inflammation.
Recent evidence has suggested that direct damage to the vascular endothelium
plays a critical role in the onset of this active feedback loop [14]. Studies have
shown that radiation exposure in the small intestine will result in a decrease of
microvascular thrombomodulin, which ultimately leads to inefficient reduction of
thrombin, thereby disrupting the microvascular coagulation system [9, 15]. This
excess thrombin has been shown to play a role in the activation of fibroblasts,
thus perpetuating the inflammatory response leading to tissue fibrosis. Active
feedback of TGF-8 and TNF-a sustains the suppressed thrombomodulin levels,
ultimately contributing to the chronic nature of the inflammation response.
Late radiation effects in the rat brain have been correlated to vascular
radiation damage using a similar selective irradiation modality to what has been
described in this thesis. Low molecular weight boron compounds (that do not
cross the blood-brain barrier), coupled to thermal neutron irradiation, were used
to selectively elevate the dose to the vascular endothelium in the rat brain. The
main conclusions from these studies showed that vascular damage is the critical
factor of the development of late white-matter necrosis [16], while neural
progenitor cell loss in the subgranular zone (SGZ) is independent of vascular
dose [17].
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The selective vascular irradiation technique, which has been described in
this thesis, is perfectly suited to elucidate the underlying mechanisms behind late
radiation effects in normal tissues outside of the central nervous system. Various
analytical techniques exist that allow for the direct measurement of inflammatory
cytokine (e.g. - TNF-a, ICAM-1, IL-1b, IL-6 and TGF-f) levels in tissue following
radiation exposure. Real-time polymerase chain reaction (PCR) and DNA
microarray analyses were performed on tissue following uniform or selective
vascular irradiation conditions. RNA extraction and real-time PCR protocols were
established for mouse small intestine and brain. Independent real-time PCR
measurements were performed on mouse tissue by the laboratory of M. Kerry
O'Banion at the University of Rochester. DNA microarray analysis was performed
on mouse tissue with the help of Rebecca Fry in the Center of Environmental
Health Sciences (CEHS) at MIT. Inflammatory cytokines that were measured in
more than one of the three different analysis techniques (real-time PCR at MIT,
real-time PCR at University of Rochester, DNA microarray analysis MIT) were
compared. The genome-wide data afforded by DNA microarray analysis allowed
the construction of interactomes to reveal the signaling networks that were up-
regulated due to radiation exposure in general and those networks that were
uniquely up-regulated due to vascular damage. The pilot data obtained from
these studies indicate that there may be a vascular component to the onset of
late radiation effects in normal tissue. These results will serve as an interesting
segue into another project exploring the specific role of vascular damage in the
onset of late radiation effects. Details of the specific radiation damage
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mechanisms could prove useful in the development of methods to treat or
prevent radiation damage in normal tissues either during tumor therapy or after
accidental or malevolent radiation exposures.
5.2 Materials and Methods
5.2.1 Mouse irradiations
Female C57B1/6 mice (8-12 weeks old) were irradiated whole-body using
137Cs gamma rays, epithermal neutrons, epithermal neutrons + boronated
liposomes or epithermal neutrons + BPA. Gamma rays from a 137Cs irradiator
were delivered at a dose rate of 0.69 Gy min-', and epithermal neutrons from the
MIT reactor were delivered at a dose rate of 0.57 Gy min-'. The numbers of mice
irradiated under each condition are summarized in Table 5-1 below:
Table 5-1: Mouse numbers and irradiation conditions
Irradiation Group Number of Mice
Control 4
20 Gy gamma rays 4
11.9 Gy epithermal neutrons 4
3.8 Gy epithermal neutrons 4
3.8 Gy epithermal neutrons +
boronated liposomes 4
3.8 Gy epithermal neutrons + BPA 3
151
10B concentrations in blood at the time of neutron irradiation in mice that received
boronated liposomes were 118±12 pg 10Bi/g. 10B concentrations in blood and
tissue in mice that received BPA were ~13 pg 10Bi/g. Mice were humanely killed 2
hrs after irradiation, and tissues were immediately processed for mRNA
extraction.
5.2.2 RNA extraction and real-time PCR protocols for irradiated mouse tissue
mRNA was extracted from brain and small intestine (jejunum) using the
RNeasy RNA extraction columns from Qiagen. Residual genomic DNA was
removed by treatment with 1 unit DNAse I (Invitrogen) for 15 min at room
temperature. The DNAse reactions were inactivated by addition of 1 pL of 25mM
EDTA and heating for 10 min at 650C. Total RNA was quantified using standard
spectrophotometric techniques. RNA (1 pg) was reverse transcribed using the
Omniscript RT kit from Qiagen, and subsequent cDNA samples were stored at
-800C until further use. Real-time PCR was performed on the Applied Biosystems
7500 Fast Real-time PCR system while using SYBR Green PCR Master Mix
(Applied Biosystems). Each reaction volume contained 25pL SYBR Green PCR
Master Mix, 21pL RNAse-free water, 1.5pL forward primer (GAPDH, TNF-a or
ICAM-1: final concentration 0.3 pM), 1.5pL reverse primer (GAPDH, TNF-a or
ICAM-1 final concentration 0.3pM) and 1 pL of cDNA for a total reaction volume
of 50pL. The primers (Table 5-2) for GAPDH, TNF-a and ICAM-1 were designed
using the Primer3 software package (MIT).
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Table 5-2: PCR primer design
Gene Primer Sequence Accession Number
for Gene Sequence
f- 5'-aacctgccaagtatgatgac
GAPDH r- 5'-gtccagggtttcttactcct BC096440
f- 5'-atgtttataaccgccagaga
ICAM-1 r- 5'-tcacacgtgttcacagtctt NM 010493
f- 5'-gccgatttgctatctcatac
TNF-a r- 5'-tgggtagagaatggatgaac NM 013693
GAPDH, which was assumed to be present in constant amounts through all
experiments, was used as the 'housekeeping' gene in this study. The log of the
fluorescence signal (log Rn) was plotted versus cycle number, and an arbitrary
line was drawn through the linear portion of the amplification curves. The value,
Ct, was defined as the cycle number where the amplification curve crossed this
threshold. The fold-change in the target genes relative to GAPDH values was
calculated using:
Fold Change = 2 -"aCt
where AACt = (Ct Target - Ct GAPDH)Dose x - (Ct Target - Ct GAPDH)Dose 0.
Real-time PCR data was obtained by M. Kerry O'Banion (University of
Rochester) using the same RNA samples that were obtained in the previously
described RNA extraction protocol. Instead of using the SYBR Green PCR
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reaction protocol, TaqMan® probes were used to measure the mRNA levels in
the mouse tissue.
5.2.3 DNA microarray experiments
mRNA samples used for the previously described real-time PCR
experiments were used in DNA microarray experiments performed by Lisa
Smeester (CEHS) and Rebecca Fry (CEHS). mRNA samples from control mice,
mice irradiated with 3.8 Gy of epithermal neutrons and mice irradiated with 3.8
Gy of epithermal neutrons plus boronated liposomes in the blood were used for
the microarray experiments. The data were processed by Rebecca Fry (CEHS),
and a genome-wide analysis was performed to determine the genes that were
up- and down-regulated in response to uniform and selective vascular irradiation
conditions. An interactome, based on this information, was then constructed,
which highlighted the signaling networks that were activated within the tissue
following radiation exposure. For clarity, the genes that were uniquely up-
regulated due to vascular damage were individually labeled in red.
5.3 Results
5.3.1 Real-time PCR results (MIT and University of Rochester)
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Figure 5-1 is a plot of the real-time PCR data (MIT) from mouse small
intestine exposed to both uniform and selective vascular irradiation conditions.
There is strong up-regulation of ICAM-1 in mice irradiated with epithermal
neutrons with corresponding weaker up-regulation of TNF-a in the same animals.
Interestingly, there is little up-regulation of both ICAM-1 and TNF-a in the animals
exposed to gamma rays. Even though ICAM-1 and TNF-a are up-regulated in all
groups exposed to epithermal neutrons, there is no evidence from this study that
vascular damage plays a role in the expression of these two inflammatory
cytokines in the mouse small intestine, as there are no differences between mice
that received a low dose of neutrons and those that received the same neutron







Figure 5-1. TNF-a and ICAM-1 mRNA levels in mouse small intestine following irradiation
with 137Cs gamma rays (gamma), epithermal neutrons (neutrons), epithermal neutrons +
BPA (neu.+BPA) or epithermal neutrons + boronated liposomes in the blood (neu.+lip.,
selective vascular irradiation).
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Figure 5-2 is a plot of the real-time PCR data (MIT) from mouse brain
exposed to both uniform and selective vascular irradiation conditions. Compared
to the mouse small intestine data, there is weaker up-regulation of ICAM-1 in
mice irradiated with epithermal neutrons with corresponding weak up-regulation
of TNF-a in the same animals. Even though ICAM-1 and TNF-a are up-regulated
in all groups exposed to epithermal neutrons, there is no evidence from this study
that vascular damage plays a role in the expression of these two inflammatory
cytokines in the mouse brain.
20 Gy 11.9 Gy 3.6 Gy 4.0 Gy 3.8 Gy
gamma neutrons neutrons neu.+ lip. neu. + BPA
Figure 5-2. TNF-a and ICAM-1 mRNA levels in mouse brain following irradiation with 137Cs
gamma rays (gamma), epithermal neutrons (neutrons), epithermal neutrons + BPA
(neu.+BPA) or epithermal neutrons + boronated liposomes in the blood (neu.+Iip.,
selective vascular irradiation).
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Figure 5-3 is a plot of the real-time PCR data (mouse small intestine)
obtained by M. Kerry O'Banion at the University of Rochester on the same RNA
samples used in the MIT real-time PCR studies. 11.9 Gy of neutrons caused a
higher up-regulation in TNF-a, IL-6 and ICAM-1 than 20 Gy of gamma rays.
Figure 5-3 (A) represents inflammatory cytokine expression after a low dose of
epithermal neutrons. In Figure 5-3 (B), extra dose was selectively delivered to the
vasculature to result in a vascular dose of ~ 12 Gy. One can see from this study
that the added dose selectively delivered to the vasculature may have caused an
increase in inflammatory cytokine levels compared to Figure 5-3 (A) (p<0.001 for


















20 Gy 11.9 Gy 3.8 Gy 3.8 Gy 3.8 Gy
gamma neutrons neutrons neu.+ lip. neu.+ BPA
Figure 5-3. Expression of TNF-a, IL-6 and ICAM-1 in mouse small intestine following
uniform whole-body and selective vascular irradiation conditions; measured using real-
time PCR. A) Inflammatory cytokine levels following uniform neutron irradiation. B)
Inflammatory cytokine levels following selective vascular irradiation conditions.
Figure 5-4 is a plot of the real-time PCR data (mouse brain) obtained by M.
Kerry O'Banion at the University of Rochester on the same RNA samples used in
the MIT real-time PCR studies. IL-6 expression was suppressed in the mouse
brain, while TNF-a and ICAM-1 were up-regulated (but to a lesser extent than in







rays elicited the largest response in terms of TNF-a and ICAM-1 expression.
Figure 5-4 (A) represents inflammatory cytokine expression after a low dose of
epithermal neutrons. In Figure 5-4 (B), extra dose was selectively delivered to the
vasculature to result in a vascular dose of ~ 12 Gy. One can see from this study
that the added dose selectively delivered to the vasculature may have caused an
increase in inflammatory cytokine levels compared to Figure 5-4 (A) (p<0.04 for
ICAM-I. The difference between A and B is not statistically significant for TNF-a
and IL-6.).
control 20 Gy 11.9 Gy 3.8 Gy 3.8 Gy 3.8 Gy
gamma neutrons neutrons neu.+ lip. neu.+ BPA
Figure 5-4. Expression of TNF-a, IL-6 and ICAM-1 in mouse brain following uniform whole-
body and selective vascular irradiation conditions; measured using real-time PCR. A)
Inflammatory cytokine levels following uniform neutron irradiation. B) Inflammatory
cytokine levels following selective vascular irradiation conditions.
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5.3.2 DNA microarray results (MIT CEHS)
DNA microarray analysis was performed on RNA samples (brain and
small intestine) taken from control mice and mice irradiated with neutrons alone
or neutrons plus boronated liposomes in the blood. The relative genome-wide
changes caused by irradiation with neutrons alone or neutrons plus boronated
liposomes were examined in these experiments. The total number of genes
screened in the microarray experiments was 28,295. Of these, 679 were
modulated by treatment with neutrons alone (where modulation is defined as a
1.5-fold change relative to controls at p<0.05), whereas treatment with neutrons
Figure 5-5. Venn diagram showing the numbers of modulated genes measured in the DNA
microarray experiments (mouse small intestine).
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plus liposomes resulted in modulation of 852 genes, relative to control mice.
Many of these genes (397) were shared by the two conditions (neutrons alone or
neutrons plus boronated liposomes). Of particular interest to us is the subset of
455 modulated genes that were uniquely modulated due to selective vascular
irradiation. Specifically, 152 genes were uniquely up-regulated and 303 genes
were down-regulated in response to selective vascular irradiation (Figure 5-5).
We analyzed the interactions and molecular pathways of the gene
products and transcripts that were uniquely up-regulated due to selective
vascular irradiation. We identified a highly significant (p<10 1 8) large interactome
that connects the up-regulated genes unique to the selective vascular irradiation
groups. Figure 5-6 shows part of the genome-wide interactome that was created
from the microarray data. It shows that the NF-KB sub-network was activated due
to radiation exposure, and the genes that were uniquely up-regulated due to
vascular damage are indicated in red. It turns out that NF-KB was up-regulated
due to vascular damage and is connected to the TNF-a signaling cascade. The
fact that TNF-a is not highlighted in red does not mean that it was not up-
regulated in the neutrons plus boronated liposomes group. It happened to be up-
reguated in both the neutrons only and selective vascular irradiation groups (see
Figure 5-3).
Key players in the inflammation response and cellular function are
embedded within the large interactome. The signaling networks that were most
strongly expressed in the neutrons only (Figure 5-5; 679 genes) and overlap
groups (Figure 5-5; 397 genes) are involved in the cell cycle, cell death, cancer,
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DNA repair and the immune response. Those networks up-regulated in the
neutrons plus boronated liposomes group (Figure 5-5; 852 genes) are also
involved in the cell cycle, DNA repair and cell death, but when the overlap genes
are subtracted from the neutrons plus 10B group, the network most strongly up-
regulated in the remaining group (Figure 5-5, 152 genes) is intimately involved in
cell death, hematological system development, inflammatory disease and the
immune response. These results support our hypothesis that vascular damage
may be involved in the inflammation response following radiation exposure.
C1PI3F1O
Figure 5-6. Interactome indicating the specific up-regulation of the NF-KB sub-network.
The red-highlighted genes represent those uniquely up-regulated due to vascular damage.
5.3.3 Trend comparison between genes that were measured in more than one of
the analysis techniques described above
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Table 5-3 lists the fold-change values for the genes that were measured in
more than one of the three analysis techniques (real-time PCR (Schuller), real-
time PCR (O'Banion), DNA microarray analysis (Fry)). Most of the genes show a
similar trend when compared across the three analysis techniques. The
exceptions (Table 5-3, yellow highlighted) are: TNF-a (20 Gy gamma-rays)
measured by Schuller (down-regulation) and O'Banion (up-regulation); IL-6 (3.8
Gy N and 3.8 Gy N+L) measured by O'Banion (up-regulation) and Fry (no
change). In all cases, the magnitudes of gene expression measured in each
analysis technique were different. The differences in overall magnitude of gene
expression between the three analysis techniques can be attributed to
differences in primer design (and type) and laboratory technique for real-time
PCR, or, in the case of the DNA microarray results, a different analysis technique
altogether. Therefore, the overall trend of gene expression is a better metric to
use when comparing the gene expression levels. The threshold for change
(either up- or down-regulation) was a 1.5-fold change from control values. A
student's t-test was applied to each comparison to determine if values were
significantly different from control values when the decision of up-regulation,
down-regulation or 'no change' was made (p<0.05 was considered significant for
these comparisons).
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Table 5-3: Values for gene expression from Schuller, O'Banion and Fry.
3.8 Gy
2 0 Gy 11.9 Gy N 3.8 Gy N 3.8 Gy N+L N+BPA
Gene S O F S O F S O F S O F S O F
TNF-a 0.7 2.4 2.5 7.5 3.6 4.7 1.7 3.4 6.4 1.6 3.5 9.9
ICAM-1 1.9 6.2 24.1 11.2 14.2 5.1 3.4 13.2 7.0 3.7 26.5 10.5
IL-lb 1.6 -1.1 1.1 -1.1
IL-6 3.1 1.1 8.1 1.1
TGF-?- 1.3 1.2 1.2 1.3
1 Real-time PCR performed by Schuller at MIT.
2 Real-time PCR performed by O'Banion at University of Rochester.
3 DNA microarray analysis performed by Fry at MIT.
Not statistically different from control.
n.b. - A blank cell indicates that the gene was not measured using that particular
technique.
5.4 Discussion
The technique for selective irradiation of the vascular endothelium, as
described in this thesis, allows for the study of the role vascular radiation damage
in the normal tissue radiation response, both early and late. The technique is
ideally suited for mechanistic studies involving vascular damage in tissue outside
of the central nervous system (CNS), where the blood-brain barrier can be used
to selectively manipulate the microvasculature. Coderre et al. have previously
employed a similar methodology in the rat CNS where the blood-brain barrier
was used to restrict the widely used BNCT compound, BSH, to the blood.
Subsequent irradiation with thermal neutrons selectively elevated the dose
delivered to the CNS microvasculature. They were able to show that vascular
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damage was responsible for the onset of late (7 months) necrosis in the rat
spinal cord [16, 18-21]. In these studies, O-2A glial progenitor cells survived
selective vascular irradiation conditions, which indicated that vascular radiation
damage played a critical role in the onset of late radiation effects but had no
effect on the early radiation response in that system. Similar studies were carried
out in the rat brain where the loss of neural precursor cells was correlated with
stem cell dose and not the added dose selectively delivered to the vasculature
[17]. A similar, biphasic trend has emerged from the mouse small intestine
studies conducted in this thesis; that early radiation effects (intestinal crypt stem
cell loss and the gastrointestinal syndrome) are due to direct radiation damage to
the proliferative stem cell populations regenerating the tissue, while late effects
(chronic inflammation and fibrosis) may be due to damage to the vasculature.
Inflammation is a normal response to tissue injury that starts with the
activation of vascular endothelial cells by pro-inflammatory cytokines (such as IL-
1, IL-6 and TNF-a) and the recruitment of neutrophils to the site of injury.
Circulating neutrophils attach to the activated vascular endothelium through
receptor-ligand interactions between integrins and selectins that are expressed
on both neutrophils and activated vascular endothelial cells. Upon attachment,
endothelial cells allow for the extravasation of neutrophils from the blood stream
to the site of injury, where chemotactic molecules are released that serve to
recruit other players in the inflammation response such as macrophages and
mast cells. In normal wound healing, the production of pro-inflammatory
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cytokines is closely followed by the release of anti-inflammatory cytokines to
ultimately lead to full tissue recovery [17].
Chronic inflammation is a process where either the initiating damage
stimulus remains present at the site of tissue injury or the active mechanism for
suppressing pro-inflammatory signaling has been distrupted. Chronic
inflammation is also involved with neoplastic progression [22, 23]. Radiation has
been shown to initiate the inflammation response in normal tissues [24], and it
has been shown to initiate the activation of inflammatory cytokines ultimately
leading to fibrosis [25]. Late radiation effects exhibit many of the same
characteristics present in chronic inflammation, such as a continuous cytokine
signaling cascade and neoplastic progression. This radiation-induced cytokine
cascade establishes a state of chronic inflammation, which ultimately leads to
permanent tissue changes such as fibrosis [10].
In normal wound healing, fibrosis promoting proteins such as transforming
growth factor-fl (TGF- ,8) and connective tissue growth factor (CTGF) are in a
delicate balance with fibrosis inhibiting proteins such as TNF-a among others [1,
8, 26-28]. However, in the late fibrogenic response to radiation, this balance
between fibrosis promoters and inhibitors is disrupted, and the wound healing
process is perpetuated over long periods of time [1]. This type of radiation
response has been likened to a 'wound that does not heal' [11, 15, 29].
TGF- fl is a strong profibrotic molecule that is intimately tied to cellular
differentialtion and proliferation. As such, it has been classified as both a cytokine
and growth factor (as its name suggests). It is involved with embryonic
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development, cell-cycle control and wound healing, and its dysfunction has been
linked to cancer and fibrotic diseases such as arteriosclerosis, rheumatoid
arthritis and scleroderma [1]. TGF- f accumulates in the extra-cellular matrix in
an inactive form, and must be activated by dissociation from its associated
latency associated peptide (LAP) [1, 30]. Thus, an abundant supply of inactive
TGF- f is present in tissue that can be rapidly activated in response to a damage
event. It is known that ionizing radiation can activate TGF- f, and activation
occurs rapidly (~-1 h post-irradiation) starting with doses as low as 0.1 Gy [1, 31-
33].
The TGF- f signaling pathway is known in great detail, but the reason for
the persistent cytokine signaling cascades in chronic inflammation is still
unknown. Some evidence suggests that damage to the microvasculature and
subsequent tissue hypoxia could motivate fibrogenesis in tissues following
radiation exposure [34, 35]. Radiation damage has been described as a complex
wound caused by vascular damage and subsequent dysregulation of the
coagulation system leading to chronic inflammation and fibrosis [15, 36]. The
radioprotector, amifostine, which does not cross the blood-brain barrier, has been
used to selectively protect the vasculature of the rat brain. These studies have
shown that selective protection of the vascular endothelium in the CNS can save
the CNS from late radiation effects [37-40]. Clearly, vascular damage plays an
integral role in the onset of late radiation effects in the CNS, and the results from
the preliminary studies presented in this chapter may indicate that vascular
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damage may play a similar role in the onset of late effects (fibrosis) outside of the
CNS; in this case, the mouse small intestine.
The process of fibrogenesis in normal tissues following radiation exposure
is a complex interplay between multiple cell types and signaling pathways. Our
selective vascular irradiation technique allows us to irradiate one target cell
population (vascular endothelium) while keeping all others relatively unscathed
(3x less dose). We have used various molecular biology techniques (real-time
PCR and DNA microarray analysis) to measure inflammatory cytokine (mRNA)
levels in tissue following uniform and selective vascular irradiation conditions.
Although it is impossible, at this time, to make absolute conclusions about
specific radiation damage mechanisms involved with the radiation-induced
inflammation response from the data presented in this chapter, it is possible to
define overall trends in inflammatory cytokine expression that will hopefully lead
to further studies in the future.
We set out to concentrate on some of the primary molecules involved with
the inflammation response. We chose to concentrate on TNF-a, ICAM-1
(intercellular adhesion molecule-I), IL-6, IL-1 b and TGF-f? in these pilot studies.
TNF-a and ICAM-1 levels were measured using the three available analysis
techniques described earlier (real-time PCR at MIT and University of Rochester;
DNA microarray analysis at MIT), while the rest of the cytokines were measured
using two of the available three techniques (real-time PCR at MIT and University
of Rochester; real-time PCR at University of Rochester and DNA microarray
analysis at MIT). TNF-a and ICAM-1 were up-regulated in all three of the analysis
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techniques (Table 5-3) and for each of the irradiation conditions outlined above
(except Schuller 20 Gy gamma rays). IL-6, IL-1 b and TGF-f? levels were
measured by O'Banion and Fry (Table 5-3). IL-6 was up-regulated in the
O'Banion real-time PCR measurements but did not change in the Fry DNA
microarray measurements (for 3.8 Gy N and 3.8 Gy N+L). IL-lb levels did not
change relative to control levels in both the O'Banion and Fry measurements (for
3.8 Gy N and 3.8 Gy N+L). TGF-,8 levels did not change relative to control levels
for both O'Banion and Fry (3.8 Gy N and 3.8 Gy N+L). The trends that arose from
the comparison between O'Banion and Fry for IL-6, IL-1 b and TGF-f,8 may have
resulted from fundamental differences between real-time PCR and DNA
microarray analysis. Also, each gene might follow a different time-course in terms
of up- or down-regulation following radiation exposure. Given that these studies
were conducted at one fixed time point (2 hrs post-irradiation), further time-
course studies might reveal interesting kinetics for these three genes. We would
expect to see persistent up-regulation of inflammatory signaling molecules weeks
to months after radiation exposure, specifically in the selective vascular
irradiation groups.
While the real-time PCR measurements performed by Schuller at MIT do
not show evidence that vascular radiation damage plays a role in the early
release of inflammatory cytokines, TNF-a and ICAM-1, in the mouse small
intestine and brain (Figures 5-1 & 5-2), the O'Banion real-time PCR and Fry DNA
microarray analysis techniques do show evidence that vascular damage may be
involved in the inflammation response (Figures 5-3, 5-4 & 5-6). Figure 5-3 shows
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the results from the O'Banion measurements in the small intestine under uniform
and selective vascular irradiation conditions. Figure 5-3 (A) shows the results for
TNF-a, IL-6 and ICAM-1 after a uniform neutron beam dose of 3.8 Gy. Figure 5-3
(B) shows the results for the same three genes and neutron dose but with a
higher dose selectively delivered to the vasculature (-12 Gy). Although there
seems to be an indication that the added dose selectively delivered to the
vasculature caused the increase in levels seen in Figure 5-3 (B), IL-6 is the only
gene in Figure 5-3 (B) that is significantly greater than (A). Figure 5-4 shows the
results from the O'Banion measurements in the mouse brain under uniform and
selective vascular irradiation conditions. Figure 5-4 (A & B) are the results of
same irradiation conditions as Figure 5-3 (A & B). Again, there seems to be an
indication that the added dose selectively delivered to the vasculature caused the
increase in levels seen in Figure 5-4 (A). ICAM-1 is the only gene in Figure 5-4
(B) that is significantly greater than (A). Figure 5-6 is an interactome (created by
Rebecca Fry from the group of genes up-regulated due to vascular damage
(Figure 5-5; 152 genes)) that shows the up-regulation of the NF-KB sub-network.
The genes highlighted in red are those uniquely up-regulated due to vascular
damage. Other networks upregulated from that same group are involved in cell
death, the cell cycle, inflammatory disease and the immune response.
These preliminary data merely hint at the role of vascular damage in the
onset of late radiation effects in normal tissues. The selective vascular irradiation
technique that has been developed in this thesis is ideally suited to elucidate the
subtle role of vascular damage in the complex process of chronic inflammation
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and fibrogenesis. The beauty of this technique is that it can be applied to any
tissue where vascular damage may play an important role in the radiation
response. This is also true for tumors where there has been intense research into
the role of tumor vasculature in tumor growth and development, which has led to
anti-angiogenic therapies. Radiation endotheliology is a fruitful and interesting
field that will have far reaching impact in radiation oncology and nuclear medicine.
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Chapter 6: Future Work
This thesis describes a generalized methodology to selectively irradiate
the vascular endothelium. Careful dosimetric considerations were made for both
the uniform neutron beam dose and the added dose selectively delivered to the
vascular endothelium from the boron neutron capture reactions restricted to the
blood. Even though the thermal neutron flux and blood-boron concentrations are
known at the time of irradiation, the final dose to the vascular wall is a calculation
that includes not only those measured parameters but also terms that are based
in modeling and simulation. Therefore, the dose to the vascular endothelium is
not a measured value but, rather, a calculation that is based in real measurement.
Current radiation dosimetry techniques do not allow for intravascular (in vivo)
measurements to determine the dose delivered to the vascular wall. Therefore, it
is necessary to conduct studies to directly measure the damage to the vascular
endothelium in a biological system, where the physiological response to selective
vascular irradiation can be used to determine the extent of vascular damage.
Blood-brain barrier dispruption following selective vascular irradiation is
one such physiological response that may directly reveal the extent of vascular
damage in that system [1, 2]. One potential experiment could involve subjecting
the CNS to selective vascular irradiation conditions, waiting an appropriate period
of time to allow blood-brain barrier disruption to occur, introducing a dye that will
pass through the blood-brain barrier following disruption and measuring the
amount of dye leakage into the CNS tissue using spectrophotometric techniques
(to measure dye concentration). The amount of dye leakage could then be
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correlated to vascular dose and serve as a measure of vascular damage
following selective vascular irradiation conditions*.
Another physiological response that could be useful in determining the
extent of vascular damage due to selective vascular irradiation, and one that has
been studied in great detail, is brain capillary drop-out following radiation
exposure. Lyubimova and Hopewell used the radio-protector, Gammaphos, to
selectively protect the brain endothelium from a dose sufficient to cause late
radiation necrosis in the rat CNS. They scored the number of surviving
endothelial cells at various times post-irradiation (up to 65 weeks), and were able
to correlate endothelial cell loss with the onset of necrosis and vascular
abnormalities. Gammaphos selectively protected the brain endothelium, which
resulted in reduced radiation-induced necrosis [3]. Similar histological techniques
can be used to measure capillary drop-out and necrosis following selective
vascular irradiation conditions, and these can be used to determine the extent
vascular damage.
The gene expression studies conducted in Chapter 5 indicate that there
are inflammatory changes in the small intestine following selective vascular
irradiation, and that there may be a vascular component to these changes. In
those studies mice were subjected to a variety of irradiation conditions, but gene
expression was only measured at one time point (2 hrs post-irradiation). A
complete time course (2 hrs to months post-irradiation) and dose response for
inflammatory cytokine expression using DNA microarray and real-time PCR
* Rebecca L. Raabe is currently performing these studies for her master's thesis (Department of
Nuclear Science and Engineering, MIT, expected August, 2007).
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analysis may reveal the specific role of vascular damage in the onset of chronic,
radiation-induced inflammatory signaling leading to fibrosis in the small intestine.
It might also be pertinent to conduct low dose experiments to establish dose
thresholds for inflammatory cytokine expression. Increasing the blood-boron
concentration as high as possible (using new 10B compounds) will allow one to
use lower neutron beam doses to achieve similarly high vascular doses to the
ones used in Chapter 5. Reducing the tissue damage due to the neutron beam
dose will allow one to observe cytokine expression due to vascular damage
alone.
The goal of this thesis was to develop a generalized methodology to
selectively irradiate the vascular endothelium that can be applied to any tissue or
tumor. The small intestine was chosen for proof-of-principle studies, because it
has interesting radiation pathology, both early and late. This same methodology
can also be applied to other tissues where the role of vascular damage in the
onset of early and late effects is still a question. There have been extensive
studies in the CNS (described earlier) using similar vascular irradiation
techniques. The technique described in this thesis can be applied to the lung and
tumor where there are, as yet, unresolved controversies (described earlier)
regarding the role of vascular damage in these tissues.
The results from these proposed studies will lend remarkable insight into
the role of vascular damage in normal tissue radiation pathology. These insights
will probably contain information on specific damage mechanisms involved in
early and late radiation effects. Based on this information, interventional drugs
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can be developed that can be used to protect tissues from debilitating radiation
effects. This will prove invaluable to clinicians and first responders as they try to
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